The name of this superfamily has been modified since the most recent official CATH+ release (v4_3_0). At the point of the last release, this superfamily was named:

"
Erythroid Transcription Factor GATA-1, subunit A
".

Functional Families

Overview of the Structural Clusters (SC) and Functional Families within this CATH Superfamily. Clusters with a representative structure are represented by a filled circle.
« Back to all FunFams

FunFam 1: GATA transcription factor (GATAd)

Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.

There are 87 GO terms relating to "molecular function"

The search results have been sorted with the annotations that are found most frequently at the top of the list. The results can be filtered by typing text into the search box at the top of the table.
GO Term Annotations Evidence
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
32 O09100 (/IPI) O09100 (/IPI) P15976 (/IPI) P17678 (/IPI) P17679 (/IPI) P23769 (/IPI) P23769 (/IPI) P23769 (/IPI) P23769 (/IPI) P23769 (/IPI)
(22 more)
DNA-binding transcription factor activity GO:0003700
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a gene to modulate transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units, and include bacterial operons.
19 P15976 (/IDA) P23769 (/IDA) P23769 (/IDA) P23769 (/IDA) P23769 (/IDA) P23769 (/IDA) P23771 (/IDA) P23772 (/IDA) P23772 (/IDA) P46152 (/IDA)
(9 more)
DNA binding GO:0003677
Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
17 A0A0R4IB15 (/IDA) O09100 (/IDA) O09100 (/IDA) P15976 (/IDA) P17679 (/IDA) P43429 (/IDA) P43694 (/IDA) P43694 (/IDA) P46152 (/IDA) P97489 (/IDA)
(7 more)
Transcription regulatory region DNA binding GO:0044212
Interacting selectively and non-covalently with a DNA region that regulates the transcription of a region of DNA, which may be a gene, cistron, or operon. Binding may occur as a sequence specific interaction or as an interaction observed only once a factor has been recruited to the DNA by other factors.
14 P23771 (/IDA) P23772 (/IDA) P23772 (/IDA) P23825 (/IDA) P43694 (/IDA) P43694 (/IDA) P43695 (/IDA) P43695 (/IDA) P46152 (/IDA) P46153 (/IDA)
(4 more)
Sequence-specific DNA binding GO:0043565
Interacting selectively and non-covalently with DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA e.g. promotor binding or rDNA binding.
13 P17679 (/IDA) P23772 (/IDA) P23772 (/IDA) P43429 (/IDA) P46153 (/IDA) P70005 (/IDA) P91623 (/IDA) Q05AJ3 (/IDA) Q08369 (/IDA) Q61169 (/IDA)
(3 more)
Transcription factor binding GO:0008134
Interacting selectively and non-covalently with a transcription factor, a protein required to initiate or regulate transcription.
12 P23769 (/IPI) P23769 (/IPI) P23769 (/IPI) P23769 (/IPI) P23769 (/IPI) P23771 (/IPI) P43694 (/IPI) P43694 (/IPI) P46152 (/IPI) P46153 (/IPI)
(2 more)
DNA-binding transcription factor activity, RNA polymerase II-specific GO:0000981
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a RNA polymerase II-transcribed gene to modulate transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units.
11 P23769 (/IDA) P23769 (/IDA) P23769 (/IDA) P23769 (/IDA) P23769 (/IDA) P46152 (/IDA) P52168 (/IDA) P52168 (/IDA) P97489 (/IDA) Q08369 (/IDA)
(1 more)
DNA-binding transcription factor activity, RNA polymerase II-specific GO:0000981
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a RNA polymerase II-transcribed gene to modulate transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units.
11 P15976 (/ISM) P23769 (/ISM) P23769 (/ISM) P23769 (/ISM) P23769 (/ISM) P23769 (/ISM) P23771 (/ISM) P43694 (/ISM) P43694 (/ISM) Q92908 (/ISM)
(1 more)
DNA-binding transcription factor activity, RNA polymerase II-specific GO:0000981
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a RNA polymerase II-transcribed gene to modulate transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units.
11 P15976 (/NAS) P23769 (/NAS) P23769 (/NAS) P23769 (/NAS) P23769 (/NAS) P23769 (/NAS) P23771 (/NAS) P43694 (/NAS) P43694 (/NAS) Q92908 (/NAS)
(1 more)
Enhancer sequence-specific DNA binding GO:0001158
Interacting selectively and non-covalently with a specific sequence of DNA that is part of an enhancer, a transcription regulatory region that is somewhat distal from the core promoter and which enhances transcription from that promoter.
11 P17679 (/IDA) P23769 (/IDA) P23769 (/IDA) P23769 (/IDA) P23769 (/IDA) P23769 (/IDA) P23772 (/IDA) P23772 (/IDA) P46152 (/IDA) P46153 (/IDA)
(1 more)
Chromatin binding GO:0003682
Interacting selectively and non-covalently with chromatin, the network of fibers of DNA, protein, and sometimes RNA, that make up the chromosomes of the eukaryotic nucleus during interphase.
11 O09100 (/IDA) O09100 (/IDA) P17679 (/IDA) P23769 (/IDA) P23769 (/IDA) P23769 (/IDA) P23769 (/IDA) P23769 (/IDA) P43429 (/IDA) Q08369 (/IDA)
(1 more)
RNA polymerase II proximal promoter sequence-specific DNA binding GO:0000978
Interacting selectively and non-covalently with a specific upstream regulatory DNA sequence (transcription factor recognition sequence or binding site) located in the proximal promoter of a gene transcribed by RNA polymerase II. The proximal promoter is in cis with and relatively close to the core promoter.
9 O09100 (/IDA) O09100 (/IDA) P15976 (/IDA) P17679 (/IDA) P23771 (/IDA) P23772 (/IDA) P23772 (/IDA) Q08369 (/IDA) Q61169 (/IDA)
Proximal promoter sequence-specific DNA binding GO:0000987
Interacting selectively and non-covalently with a specific upstream regulatory DNA sequence (transcription factor recognition sequence or binding site) located in the proximal promoter. The proximal promoter is in cis with and relatively close to the core promoter.
9 D2HDE5 (/ISS) E2RPT1 (/ISS) P23772 (/ISS) P23772 (/ISS) P23825 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
DNA-binding transcription repressor activity, RNA polymerase II-specific GO:0001227
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a RNA polymerase II-transcribed gene to repress or decrease transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units.
9 D2HDE5 (/ISS) E2RPT1 (/ISS) P23772 (/ISS) P23772 (/ISS) P23825 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
Transcription coactivator activity GO:0003713
A protein or a member of a complex that interacts specifically and non-covalently with a DNA-bound DNA-binding transcription factor to activate the transcription of specific genes. Coactivators often act by altering chromatin structure and modifications. For example, one class of transcription coregulators modifies chromatin structure through covalent modification of histones. A second ATP-dependent class modifies the conformation of chromatin. Another type of coregulator activity is the bridging of a DNA-binding transcription factor to the basal transcription machinery. The Mediator complex, which bridges transcription factors and RNA polymerase, is also a transcription coactivator.
9 D2HDE5 (/ISS) E2RPT1 (/ISS) P23772 (/ISS) P23772 (/ISS) P23825 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
E-box binding GO:0070888
Interacting selectively and non-covalently with an E-box, a DNA motif with the consensus sequence CANNTG that is found in the promoters of a wide array of genes expressed in neurons, muscle and other tissues.
9 D2HDE5 (/ISS) E2RPT1 (/ISS) P23772 (/ISS) P23772 (/ISS) P23825 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
DNA-binding transcription factor activity GO:0003700
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a gene to modulate transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units, and include bacterial operons.
8 O09100 (/ISO) O09100 (/ISO) P17679 (/ISO) P23772 (/ISO) P23772 (/ISO) P97489 (/ISO) Q08369 (/ISO) Q61169 (/ISO)
Sequence-specific DNA binding GO:0043565
Interacting selectively and non-covalently with DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA e.g. promotor binding or rDNA binding.
7 O09100 (/ISO) O09100 (/ISO) P17679 (/ISO) P23772 (/ISO) P23772 (/ISO) Q08369 (/ISO) Q61169 (/ISO)
Transcription regulatory region DNA binding GO:0044212
Interacting selectively and non-covalently with a DNA region that regulates the transcription of a region of DNA, which may be a gene, cistron, or operon. Binding may occur as a sequence specific interaction or as an interaction observed only once a factor has been recruited to the DNA by other factors.
7 D2HDE5 (/ISS) E2RPT1 (/ISS) P23825 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
DNA-binding transcription factor activity, RNA polymerase II-specific GO:0000981
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a RNA polymerase II-transcribed gene to modulate transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units.
6 P15976 (/ISA) P23771 (/ISA) P43694 (/ISA) P43694 (/ISA) Q92908 (/ISA) Q9BWX5 (/ISA)
RNA polymerase II transcription factor binding GO:0001085
Interacting selectively and non-covalently with an RNA polymerase II transcription factor, any protein required to initiate or regulate transcription by RNA polymerase II.
6 P15976 (/IPI) P17679 (/IPI) P43694 (/IPI) P43694 (/IPI) P52168 (/IPI) P52168 (/IPI)
DNA-binding transcription activator activity, RNA polymerase II-specific GO:0001228
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a RNA polymerase II-transcribed gene to activate or increase transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units.
6 O09100 (/IDA) O09100 (/IDA) P15976 (/IDA) P17679 (/IDA) P23772 (/IDA) P23772 (/IDA)
DNA-binding transcription factor activity GO:0003700
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a gene to modulate transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units, and include bacterial operons.
6 D2HDE5 (/ISS) E2RPT1 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
Transcription factor binding GO:0008134
Interacting selectively and non-covalently with a transcription factor, a protein required to initiate or regulate transcription.
6 O09100 (/ISO) O09100 (/ISO) P23772 (/ISO) P23772 (/ISO) Q08369 (/ISO) Q61169 (/ISO)
C2H2 zinc finger domain binding GO:0070742
Interacting selectively and non-covalently with a C2H2-type zinc finger domain of a protein. The C2H2 zinc finger is the classical zinc finger domain, in which two conserved cysteines and histidines co-ordinate a zinc ion.
6 P15976 (/IPI) P23769 (/IPI) P23769 (/IPI) P23769 (/IPI) P23769 (/IPI) P23769 (/IPI)
DNA binding GO:0003677
Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
5 P43691 (/ISS) P43694 (/ISS) P43694 (/ISS) Q0Q0E4 (/ISS) Q91677 (/ISS)
Transcription coactivator activity GO:0003713
A protein or a member of a complex that interacts specifically and non-covalently with a DNA-bound DNA-binding transcription factor to activate the transcription of specific genes. Coactivators often act by altering chromatin structure and modifications. For example, one class of transcription coregulators modifies chromatin structure through covalent modification of histones. A second ATP-dependent class modifies the conformation of chromatin. Another type of coregulator activity is the bridging of a DNA-binding transcription factor to the basal transcription machinery. The Mediator complex, which bridges transcription factors and RNA polymerase, is also a transcription coactivator.
5 P23771 (/IDA) P23772 (/IDA) P23772 (/IDA) P43694 (/IDA) P43694 (/IDA)
Transcription regulatory region DNA binding GO:0044212
Interacting selectively and non-covalently with a DNA region that regulates the transcription of a region of DNA, which may be a gene, cistron, or operon. Binding may occur as a sequence specific interaction or as an interaction observed only once a factor has been recruited to the DNA by other factors.
5 P23772 (/ISO) P23772 (/ISO) P97489 (/ISO) Q08369 (/ISO) Q61169 (/ISO)
RNA polymerase II regulatory region sequence-specific DNA binding GO:0000977
Interacting selectively and non-covalently with a specific sequence of DNA that is part of a regulatory region that controls the transcription of a gene or cistron by RNA polymerase II.
4 P15976 (/IDA) P23772 (/IDA) P23772 (/IDA) Q08369 (/IDA)
DNA-binding transcription factor activity, RNA polymerase II-specific GO:0000981
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a RNA polymerase II-transcribed gene to modulate transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units.
4 O09100 (/ISO) O09100 (/ISO) Q08369 (/ISO) Q61169 (/ISO)
Enhancer sequence-specific DNA binding GO:0001158
Interacting selectively and non-covalently with a specific sequence of DNA that is part of an enhancer, a transcription regulatory region that is somewhat distal from the core promoter and which enhances transcription from that promoter.
4 O09100 (/ISO) O09100 (/ISO) Q08369 (/ISO) Q61169 (/ISO)
Transcription regulatory region sequence-specific DNA binding GO:0000976
Interacting selectively and non-covalently with a specific sequence of DNA that is part of a regulatory region that controls transcription of that section of the DNA. The transcribed region might be described as a gene, cistron, or operon.
3 I3LUZ9 (/IDA) P23771 (/IDA) Q8MIM5 (/IDA)
Transcription regulatory region sequence-specific DNA binding GO:0000976
Interacting selectively and non-covalently with a specific sequence of DNA that is part of a regulatory region that controls transcription of that section of the DNA. The transcribed region might be described as a gene, cistron, or operon.
3 P17679 (/ISO) P23772 (/ISO) P23772 (/ISO)
RNA polymerase II proximal promoter sequence-specific DNA binding GO:0000978
Interacting selectively and non-covalently with a specific upstream regulatory DNA sequence (transcription factor recognition sequence or binding site) located in the proximal promoter of a gene transcribed by RNA polymerase II. The proximal promoter is in cis with and relatively close to the core promoter.
3 P17679 (/ISO) P23772 (/ISO) P23772 (/ISO)
RNA polymerase II distal enhancer sequence-specific DNA binding GO:0000980
Interacting selectively and non-covalently with a RNA polymerase II (Pol II) distal enhancer. In mammalian cells, enhancers are distal sequences that increase the utilization of some promoters, and can function in either orientation and in any location (upstream or downstream) relative to the core promoter.
3 O09100 (/IDA) O09100 (/IDA) P15976 (/IDA)
RNA polymerase II repressing transcription factor binding GO:0001103
Interacting selectively and non-covalently with an RNA polymerase II transcription repressing factor, a protein involved in negative regulation of transcription.
3 P52168 (/IPI) P52168 (/IPI) Q61169 (/IPI)
Chromatin binding GO:0003682
Interacting selectively and non-covalently with chromatin, the network of fibers of DNA, protein, and sometimes RNA, that make up the chromosomes of the eukaryotic nucleus during interphase.
3 O09100 (/ISO) O09100 (/ISO) P17679 (/ISO)
Double-stranded DNA binding GO:0003690
Interacting selectively and non-covalently with double-stranded DNA.
3 P46153 (/IDA) Q05AJ3 (/IDA) Q90410 (/IDA)
Transcription coactivator activity GO:0003713
A protein or a member of a complex that interacts specifically and non-covalently with a DNA-bound DNA-binding transcription factor to activate the transcription of specific genes. Coactivators often act by altering chromatin structure and modifications. For example, one class of transcription coregulators modifies chromatin structure through covalent modification of histones. A second ATP-dependent class modifies the conformation of chromatin. Another type of coregulator activity is the bridging of a DNA-binding transcription factor to the basal transcription machinery. The Mediator complex, which bridges transcription factors and RNA polymerase, is also a transcription coactivator.
3 P23772 (/ISO) P23772 (/ISO) Q08369 (/ISO)
Sequence-specific DNA binding GO:0043565
Interacting selectively and non-covalently with DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA e.g. promotor binding or rDNA binding.
3 P15976 (/IMP) P46152 (/IMP) Q99NH5 (/IMP)
C2H2 zinc finger domain binding GO:0070742
Interacting selectively and non-covalently with a C2H2-type zinc finger domain of a protein. The C2H2 zinc finger is the classical zinc finger domain, in which two conserved cysteines and histidines co-ordinate a zinc ion.
3 O09100 (/ISO) O09100 (/ISO) P17679 (/ISO)
RNA polymerase II regulatory region sequence-specific DNA binding GO:0000977
Interacting selectively and non-covalently with a specific sequence of DNA that is part of a regulatory region that controls the transcription of a gene or cistron by RNA polymerase II.
2 P43694 (/IGI) P43694 (/IGI)
RNA polymerase II regulatory region sequence-specific DNA binding GO:0000977
Interacting selectively and non-covalently with a specific sequence of DNA that is part of a regulatory region that controls the transcription of a gene or cistron by RNA polymerase II.
2 P17679 (/ISO) Q08369 (/ISO)
RNA polymerase II distal enhancer sequence-specific DNA binding GO:0000980
Interacting selectively and non-covalently with a RNA polymerase II (Pol II) distal enhancer. In mammalian cells, enhancers are distal sequences that increase the utilization of some promoters, and can function in either orientation and in any location (upstream or downstream) relative to the core promoter.
2 P17679 (/ISS) P43429 (/ISS)
DNA-binding transcription factor activity, RNA polymerase II-specific GO:0000981
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a RNA polymerase II-transcribed gene to modulate transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units.
2 P91623 (/ISS) Q9BWX5 (/ISS)
Proximal promoter sequence-specific DNA binding GO:0000987
Interacting selectively and non-covalently with a specific upstream regulatory DNA sequence (transcription factor recognition sequence or binding site) located in the proximal promoter. The proximal promoter is in cis with and relatively close to the core promoter.
2 P23772 (/ISO) P23772 (/ISO)
RNA polymerase II transcription factor binding GO:0001085
Interacting selectively and non-covalently with an RNA polymerase II transcription factor, any protein required to initiate or regulate transcription by RNA polymerase II.
2 P17679 (/ISO) Q08369 (/ISO)
Enhancer sequence-specific DNA binding GO:0001158
Interacting selectively and non-covalently with a specific sequence of DNA that is part of an enhancer, a transcription regulatory region that is somewhat distal from the core promoter and which enhances transcription from that promoter.
2 F1NZV5 (/IMP) P43692 (/IMP)
DNA-binding transcription repressor activity, RNA polymerase II-specific GO:0001227
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a RNA polymerase II-transcribed gene to repress or decrease transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units.
2 P23772 (/ISO) P23772 (/ISO)
DNA-binding transcription activator activity, RNA polymerase II-specific GO:0001228
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a RNA polymerase II-transcribed gene to activate or increase transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units.
2 P43694 (/IGI) P43694 (/IGI)
DNA-binding transcription activator activity, RNA polymerase II-specific GO:0001228
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a RNA polymerase II-transcribed gene to activate or increase transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units.
2 P17679 (/ISO) Q08369 (/ISO)
DNA binding GO:0003677
Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
2 P17679 (/ISO) Q08369 (/ISO)
DNA-binding transcription factor activity GO:0003700
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a gene to modulate transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units, and include bacterial operons.
2 P23771 (/IMP) Q99NH5 (/IMP)
Transcription coregulator activity GO:0003712
A protein or a member of a complex that interacts specifically and non-covalently with a DNA-bound DNA-binding transcription factor to either activate or repress the transcription of specific genes. Coregulators often act by altering chromatin structure and modifications. For example, one class of transcription coregulators modifies chromatin structure through covalent modification of histones. A second ATP-dependent class modifies the conformation of chromatin. A third class modulates interactions of DNA-binding transcription factor with other transcription coregulators.
2 P23772 (/IDA) P23772 (/IDA)
Interleukin-2 receptor binding GO:0005134
Interacting selectively and non-covalently with the interleukin-2 receptor.
2 P23772 (/IPI) P23772 (/IPI)
Protein kinase binding GO:0019901
Interacting selectively and non-covalently with a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate.
2 P46152 (/IPI) Q92908 (/IPI)
Protein kinase binding GO:0019901
Interacting selectively and non-covalently with a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate.
2 Q08369 (/ISO) Q61169 (/ISO)
Chromatin DNA binding GO:0031490
Interacting selectively and non-covalently with DNA that is assembled into chromatin.
2 P17679 (/ISS) P43429 (/ISS)
Activating transcription factor binding GO:0033613
Interacting selectively and non-covalently with an activating transcription factor, any protein whose activity is required to initiate or upregulate transcription.
2 P43694 (/ISS) P43694 (/ISS)
Sequence-specific DNA binding GO:0043565
Interacting selectively and non-covalently with DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA e.g. promotor binding or rDNA binding.
2 P43694 (/ISS) P43694 (/ISS)
Protein heterodimerization activity GO:0046982
Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer.
2 P52168 (/IPI) P52168 (/IPI)
Protein dimerization activity GO:0046983
The formation of a protein dimer, a macromolecular structure consists of two noncovalently associated identical or nonidentical subunits.
2 P23772 (/IDA) P23772 (/IDA)
Co-SMAD binding GO:0070410
Interacting selectively and non-covalently with a common mediator SMAD signaling protein.
2 P43694 (/IPI) P43694 (/IPI)
E-box binding GO:0070888
Interacting selectively and non-covalently with an E-box, a DNA motif with the consensus sequence CANNTG that is found in the promoters of a wide array of genes expressed in neurons, muscle and other tissues.
2 P23772 (/ISO) P23772 (/ISO)
HMG box domain binding GO:0071837
Interacting selectively and non-covalently with an HMG box domain, a protein domain that consists of three helices in an irregular array. HMG-box domains are found in one or more copies in HMG-box proteins, which form a large, diverse family involved in the regulation of DNA-dependent processes such as transcription, replication, and strand repair, all of which require the bending and unwinding of chromatin.
2 P23772 (/ISO) P23772 (/ISO)
Transcription regulatory region sequence-specific DNA binding GO:0000976
Interacting selectively and non-covalently with a specific sequence of DNA that is part of a regulatory region that controls transcription of that section of the DNA. The transcribed region might be described as a gene, cistron, or operon.
1 P15976 (/IMP)
RNA polymerase II proximal promoter sequence-specific DNA binding GO:0000978
Interacting selectively and non-covalently with a specific upstream regulatory DNA sequence (transcription factor recognition sequence or binding site) located in the proximal promoter of a gene transcribed by RNA polymerase II. The proximal promoter is in cis with and relatively close to the core promoter.
1 P15976 (/IMP)
RNA polymerase II distal enhancer sequence-specific DNA binding GO:0000980
Interacting selectively and non-covalently with a RNA polymerase II (Pol II) distal enhancer. In mammalian cells, enhancers are distal sequences that increase the utilization of some promoters, and can function in either orientation and in any location (upstream or downstream) relative to the core promoter.
1 P17679 (/ISO)
DNA-binding transcription factor activity, RNA polymerase II-specific GO:0000981
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a RNA polymerase II-transcribed gene to modulate transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units.
1 Q92908 (/IMP)
Proximal promoter sequence-specific DNA binding GO:0000987
Interacting selectively and non-covalently with a specific upstream regulatory DNA sequence (transcription factor recognition sequence or binding site) located in the proximal promoter. The proximal promoter is in cis with and relatively close to the core promoter.
1 P23771 (/IDA)
DNA-binding transcription repressor activity, RNA polymerase II-specific GO:0001227
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a RNA polymerase II-transcribed gene to repress or decrease transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units.
1 P23771 (/IMP)
P53 binding GO:0002039
Interacting selectively and non-covalently with one of the p53 family of proteins.
1 P17679 (/IPI)
DNA binding GO:0003677
Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
1 P23771 (/TAS)
Double-stranded DNA binding GO:0003690
Interacting selectively and non-covalently with double-stranded DNA.
1 Q61169 (/ISO)
DNA-binding transcription factor activity GO:0003700
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a gene to modulate transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units, and include bacterial operons.
1 Q16365 (/NAS)
DNA-binding transcription factor activity GO:0003700
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a gene to modulate transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units, and include bacterial operons.
1 P23771 (/TAS)
Transcription factor binding GO:0008134
Interacting selectively and non-covalently with a transcription factor, a protein required to initiate or regulate transcription.
1 P46152 (/IDA)
Zinc ion binding GO:0008270
Interacting selectively and non-covalently with zinc (Zn) ions.
1 P46152 (/TAS)
Chromatin DNA binding GO:0031490
Interacting selectively and non-covalently with DNA that is assembled into chromatin.
1 P15976 (/IDA)
Chromatin DNA binding GO:0031490
Interacting selectively and non-covalently with DNA that is assembled into chromatin.
1 P17679 (/ISO)
Activating transcription factor binding GO:0033613
Interacting selectively and non-covalently with an activating transcription factor, any protein whose activity is required to initiate or upregulate transcription.
1 P46152 (/IPI)
Activating transcription factor binding GO:0033613
Interacting selectively and non-covalently with an activating transcription factor, any protein whose activity is required to initiate or upregulate transcription.
1 Q08369 (/ISO)
NFAT protein binding GO:0051525
Interacting selectively and non-covalently with NFAT (nuclear factor of activated T cells) proteins, a family of transcription factors. NFAT proteins have crucial roles in the development and function of the immune system.
1 P46152 (/IPI)
NFAT protein binding GO:0051525
Interacting selectively and non-covalently with NFAT (nuclear factor of activated T cells) proteins, a family of transcription factors. NFAT proteins have crucial roles in the development and function of the immune system.
1 Q08369 (/ISO)
Co-SMAD binding GO:0070410
Interacting selectively and non-covalently with a common mediator SMAD signaling protein.
1 Q08369 (/ISO)
E-box binding GO:0070888
Interacting selectively and non-covalently with an E-box, a DNA motif with the consensus sequence CANNTG that is found in the promoters of a wide array of genes expressed in neurons, muscle and other tissues.
1 P23771 (/IDA)
HMG box domain binding GO:0071837
Interacting selectively and non-covalently with an HMG box domain, a protein domain that consists of three helices in an irregular array. HMG-box domains are found in one or more copies in HMG-box proteins, which form a large, diverse family involved in the regulation of DNA-dependent processes such as transcription, replication, and strand repair, all of which require the bending and unwinding of chromatin.
1 P23771 (/IPI)

There are 543 GO terms relating to "biological process"

The search results have been sorted with the annotations that are found most frequently at the top of the list. The results can be filtered by typing text into the search box at the top of the table.
GO Term Annotations Evidence
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
24 O09100 (/IDA) O09100 (/IDA) P15976 (/IDA) P17679 (/IDA) P23769 (/IDA) P23769 (/IDA) P23769 (/IDA) P23769 (/IDA) P23769 (/IDA) P23771 (/IDA)
(14 more)
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
21 A0A0R4IB15 (/IGI) A0A0R4ILP3 (/IGI) O09100 (/IGI) O09100 (/IGI) P17679 (/IGI) P23769 (/IGI) P23769 (/IGI) P23769 (/IGI) P23769 (/IGI) P23769 (/IGI)
(11 more)
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
19 O09100 (/IMP) O09100 (/IMP) P15976 (/IMP) P17679 (/IMP) P23769 (/IMP) P23769 (/IMP) P23769 (/IMP) P23769 (/IMP) P23769 (/IMP) P23771 (/IMP)
(9 more)
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
18 D2HDE5 (/ISS) E2RPT1 (/ISS) P23771 (/ISS) P23825 (/ISS) P43429 (/ISS) P43691 (/ISS) P43693 (/ISS) P43694 (/ISS) P43694 (/ISS) P46152 (/ISS)
(8 more)
Blood coagulation GO:0007596
The sequential process in which the multiple coagulation factors of the blood interact, ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages: stage 1, the formation of intrinsic and extrinsic prothrombin converting principle; stage 2, the formation of thrombin; stage 3, the formation of stable fibrin polymers.
11 P15976 (/TAS) P23769 (/TAS) P23769 (/TAS) P23769 (/TAS) P23769 (/TAS) P23769 (/TAS) P23771 (/TAS) P43694 (/TAS) P43694 (/TAS) Q92908 (/TAS)
(1 more)
Myeloid cell differentiation GO:0030099
The process in which a relatively unspecialized myeloid precursor cell acquires the specialized features of any cell of the myeloid leukocyte, megakaryocyte, thrombocyte, or erythrocyte lineages.
11 A0A0R4IB15 (/IGI) A0A0R4ILP3 (/IGI) Q05AJ3 (/IGI) Q09JY7 (/IGI) Q1JQ00 (/IGI) Q567K8 (/IGI) Q6NW63 (/IGI) Q90410 (/IGI) Q9PTJ1 (/IGI) Q9PTJ2 (/IGI)
(1 more)
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
11 P15976 (/IDA) P17679 (/IDA) P23771 (/IDA) P23772 (/IDA) P23772 (/IDA) P43694 (/IDA) P43694 (/IDA) P70005 (/IDA) P97489 (/IDA) Q08369 (/IDA)
(1 more)
Liver development GO:0001889
The process whose specific outcome is the progression of the liver over time, from its formation to the mature structure. The liver is an exocrine gland which secretes bile and functions in metabolism of protein and carbohydrate and fat, synthesizes substances involved in the clotting of the blood, synthesizes vitamin A, detoxifies poisonous substances, stores glycogen, and breaks down worn-out erythrocytes.
10 A0A0R4IB15 (/IMP) A0A0R4ILP3 (/IMP) Q09JY7 (/IMP) Q1JQ00 (/IMP) Q567K8 (/IMP) Q61169 (/IMP) Q6NW63 (/IMP) Q9PTJ1 (/IMP) Q9PTJ2 (/IMP) Q9W6U0 (/IMP)
Cardiac right ventricle morphogenesis GO:0003215
The process in which the right cardiac ventricle is generated and organized.
10 D2HDE5 (/ISS) E2RPT1 (/ISS) P23771 (/ISS) P23825 (/ISS) P43694 (/ISS) P43694 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
Ventricular septum development GO:0003281
The progression of the ventricular septum over time from its formation to the mature structure.
10 D2HDE5 (/ISS) E2RPT1 (/ISS) P23771 (/ISS) P23825 (/ISS) P43694 (/ISS) P43694 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
Negative regulation of gene expression GO:0010629
Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
10 P23769 (/IMP) P23769 (/IMP) P23769 (/IMP) P23769 (/IMP) P23769 (/IMP) P23772 (/IMP) P23772 (/IMP) P97489 (/IMP) Q05AJ3 (/IMP) Q90410 (/IMP)
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
10 D2HDE5 (/ISS) E2RPT1 (/ISS) P23771 (/ISS) P23825 (/ISS) P43694 (/ISS) P43694 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
Aortic valve morphogenesis GO:0003180
The process in which the structure of the aortic valve is generated and organized.
9 D2HDE5 (/ISS) E2RPT1 (/ISS) P23771 (/ISS) P23825 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS) Q9BWX5 (/ISS)
Positive regulation of signal transduction GO:0009967
Any process that activates or increases the frequency, rate or extent of signal transduction.
9 D2HDE5 (/ISS) E2RPT1 (/ISS) P23772 (/ISS) P23772 (/ISS) P23825 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
Positive regulation of endothelial cell migration GO:0010595
Any process that increases the rate, frequency, or extent of the orderly movement of an endothelial cell into the extracellular matrix to form an endothelium.
9 D2HDE5 (/ISS) E2RPT1 (/ISS) P23772 (/ISS) P23772 (/ISS) P23825 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
Ear development GO:0043583
The process whose specific outcome is the progression of the ear over time, from its formation to the mature structure. The ear is the sense organ in vertebrates that is specialized for the detection of sound, and the maintenance of balance. Includes the outer ear and middle ear, which collect and transmit sound waves; and the inner ear, which contains the organs of balance and (except in fish) hearing. Also includes the pinna, the visible part of the outer ear, present in some mammals.
9 D2HDE5 (/ISS) E2RPT1 (/ISS) P23772 (/ISS) P23772 (/ISS) P23825 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
Negative regulation of fat cell differentiation GO:0045599
Any process that stops, prevents, or reduces the frequency, rate or extent of adipocyte differentiation.
9 D2HDE5 (/ISS) E2RPT1 (/ISS) P23772 (/ISS) P23772 (/ISS) P23825 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
Negative regulation of cell cycle GO:0045786
Any process that stops, prevents or reduces the rate or extent of progression through the cell cycle.
9 D2HDE5 (/ISS) E2RPT1 (/ISS) P23772 (/ISS) P23772 (/ISS) P23825 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
Negative regulation of transcription, DNA-templated GO:0045892
Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.
9 D2HDE5 (/ISS) E2RPT1 (/ISS) P23772 (/ISS) P23772 (/ISS) P23825 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
Negative regulation of inflammatory response GO:0050728
Any process that stops, prevents, or reduces the frequency, rate or extent of the inflammatory response.
9 D2HDE5 (/ISS) E2RPT1 (/ISS) P23772 (/ISS) P23772 (/ISS) P23825 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
Positive regulation of protein kinase B signaling GO:0051897
Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
9 D2HDE5 (/ISS) E2RPT1 (/ISS) P23772 (/ISS) P23772 (/ISS) P23825 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
Mesenchymal to epithelial transition GO:0060231
A transition where a mesenchymal cell establishes apical/basolateral polarity, forms intercellular adhesive junctions, synthesizes basement membrane components and becomes an epithelial cell.
9 D2HDE5 (/ISS) E2RPT1 (/ISS) P23772 (/ISS) P23772 (/ISS) P23825 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
Cardioblast migration to the midline involved in heart field formation GO:0060975
The orderly movement of a cardioblast toward the midline to form the heart field. A cardioblast is a cardiac precursor cell. It is a cell that has been committed to a cardiac fate, but will undergo more cell division rather than terminally differentiating.
9 A0A0R4IB15 (/IGI) A0A0R4ILP3 (/IGI) Q09JY7 (/IGI) Q1JQ00 (/IGI) Q567K8 (/IGI) Q6NW63 (/IGI) Q9PTJ1 (/IGI) Q9PTJ2 (/IGI) Q9W6U0 (/IGI)
Lymphocyte migration GO:0072676
The movement of a lymphocyte within or between different tissues and organs of the body.
9 D2HDE5 (/ISS) E2RPT1 (/ISS) P23772 (/ISS) P23772 (/ISS) P23825 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
Negative regulation of cell motility GO:2000146
Any process that stops, prevents, or reduces the frequency, rate or extent of cell motility.
9 D2HDE5 (/ISS) E2RPT1 (/ISS) P23772 (/ISS) P23772 (/ISS) P23825 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
Negative regulation of endothelial cell apoptotic process GO:2000352
Any process that stops, prevents or reduces the frequency, rate or extent of endothelial cell apoptotic process.
9 D2HDE5 (/ISS) E2RPT1 (/ISS) P23772 (/ISS) P23772 (/ISS) P23825 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
Positive regulation of thyroid hormone generation GO:2000611
Any process that activates or increases the frequency, rate or extent of thyroid hormone generation.
9 D2HDE5 (/ISS) E2RPT1 (/ISS) P23772 (/ISS) P23772 (/ISS) P23825 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
Positive regulation of interleukin-5 secretion GO:2000664
Any process that activates or increases the frequency, rate or extent of interleukin-5 secretion.
9 D2HDE5 (/ISS) E2RPT1 (/ISS) P23772 (/ISS) P23772 (/ISS) P23825 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
Positive regulation of interleukin-13 secretion GO:2000667
Any process that activates or increases the frequency, rate or extent of interleukin-13 secretion.
9 D2HDE5 (/ISS) E2RPT1 (/ISS) P23772 (/ISS) P23772 (/ISS) P23825 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
Regulation of cellular response to X-ray GO:2000683
Any process that modulates the frequency, rate or extent of cellular response to X-ray.
9 D2HDE5 (/ISS) E2RPT1 (/ISS) P23772 (/ISS) P23772 (/ISS) P23825 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
Cell fate determination GO:0001709
A process involved in cell fate commitment. Once determination has taken place, a cell becomes committed to differentiate down a particular pathway regardless of its environment.
8 D2HDE5 (/ISS) E2RPT1 (/ISS) P23771 (/ISS) P23825 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
Mesonephros development GO:0001823
The process whose specific outcome is the progression of the mesonephros over time, from its formation to the mature structure. In mammals, the mesonephros is the second of the three embryonic kidneys to be established and exists only transiently. In lower vertebrates such as fish and amphibia, the mesonephros will form the mature kidney.
8 D2HDE5 (/ISS) E2RPT1 (/ISS) P23771 (/ISS) P23825 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
Signal transduction GO:0007165
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
8 D2HDE5 (/ISS) E2RPT1 (/ISS) P23771 (/ISS) P23825 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
Negative regulation of cell population proliferation GO:0008285
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
8 D2HDE5 (/ISS) E2RPT1 (/ISS) P23771 (/ISS) P23825 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
Male gonad development GO:0008584
The process whose specific outcome is the progression of the male gonad over time, from its formation to the mature structure.
8 D2HDE5 (/ISS) E2RPT1 (/ISS) P23771 (/ISS) P23825 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
Phosphatidylinositol 3-kinase signaling GO:0014065
A series of reactions within the signal-receiving cell, mediated by the intracellular phosphatidylinositol 3-kinase (PI3K). Many cell surface receptor linked signaling pathways signal through PI3K to regulate numerous cellular functions.
8 D2HDE5 (/ISS) E2RPT1 (/ISS) P23771 (/ISS) P23825 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
TOR signaling GO:0031929
A series of molecular signals mediated by TOR (Target of rapamycin) proteins, members of the phosphoinositide (PI) 3-kinase related kinase (PIKK) family that act as serine/threonine kinases in response to nutrient availability or growth factors.
8 D2HDE5 (/ISS) E2RPT1 (/ISS) P23771 (/ISS) P23825 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
Positive regulation of interleukin-4 production GO:0032753
Any process that activates or increases the frequency, rate, or extent of interleukin-4 production.
8 D2HDE5 (/ISS) E2RPT1 (/ISS) P23771 (/ISS) P23825 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
Regulation of cytokine biosynthetic process GO:0042035
Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of cytokines.
8 D2HDE5 (/ISS) E2RPT1 (/ISS) P23771 (/ISS) P23825 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
Norepinephrine biosynthetic process GO:0042421
The chemical reactions and pathways resulting in the formation of norepinephrine, a hormone secreted by the adrenal medulla, and a neurotransmitter in the sympathetic peripheral nervous system and in some tracts in the central nervous system. It is also the demethylated biosynthetic precursor of epinephrine.
8 D2HDE5 (/ISS) E2RPT1 (/ISS) P23771 (/ISS) P23825 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
Positive regulation of T cell differentiation GO:0045582
Any process that activates or increases the frequency, rate or extent of T cell differentiation.
8 D2HDE5 (/ISS) E2RPT1 (/ISS) P23771 (/ISS) P23825 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
Negative regulation of fat cell differentiation GO:0045599
Any process that stops, prevents, or reduces the frequency, rate or extent of adipocyte differentiation.
8 O09100 (/IMP) O09100 (/IMP) P23769 (/IMP) P23769 (/IMP) P23769 (/IMP) P23769 (/IMP) P23769 (/IMP) P23771 (/IMP)
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
8 O09100 (/ISO) O09100 (/ISO) P17679 (/ISO) P23772 (/ISO) P23772 (/ISO) P97489 (/ISO) Q08369 (/ISO) Q61169 (/ISO)
Sympathetic nervous system development GO:0048485
The process whose specific outcome is the progression of the sympathetic nervous system over time, from its formation to the mature structure. The sympathetic nervous system is one of the two divisions of the vertebrate autonomic nervous system (the other being the parasympathetic nervous system). The sympathetic preganglionic neurons have their cell bodies in the thoracic and lumbar regions of the spinal cord and connect to the paravertebral chain of sympathetic ganglia. Innervate heart and blood vessels, sweat glands, viscera and the adrenal medulla. Most sympathetic neurons, but not all, use noradrenaline as a post-ganglionic neurotransmitter.
8 D2HDE5 (/ISS) E2RPT1 (/ISS) P23771 (/ISS) P23825 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
Anatomical structure formation involved in morphogenesis GO:0048646
The developmental process pertaining to the initial formation of an anatomical structure from unspecified parts. This process begins with the specific processes that contribute to the appearance of the discrete structure and ends when the structural rudiment is recognizable. An anatomical structure is any biological entity that occupies space and is distinguished from its surroundings. Anatomical structures can be macroscopic such as a carpel, or microscopic such as an acrosome.
8 D2HDE5 (/ISS) E2RPT1 (/ISS) P23771 (/ISS) P23825 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
T cell receptor signaling pathway GO:0050852
A series of molecular signals initiated by the cross-linking of an antigen receptor on a T cell.
8 D2HDE5 (/ISS) E2RPT1 (/ISS) P23771 (/ISS) P23825 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
Pharyngeal system development GO:0060037
The process whose specific outcome is the progression of the pharyngeal system over time, from its formation to the mature structure. The pharyngeal system is a transient embryonic complex that is specific to vertebrates. It comprises the pharyngeal arches, bulges of tissues of mesoderm and neural crest derivation through which pass nerves and pharyngeal arch arteries. The arches are separated internally by pharyngeal pouches, evaginations of foregut endoderm, and externally by pharyngeal clefts, invaginations of surface ectoderm. The development of the system ends when the stucture it contributes to are forming: the thymus, thyroid, parathyroids, maxilla, mandible, aortic arch, cardiac outflow tract, external and middle ear.
8 D2HDE5 (/ISS) E2RPT1 (/ISS) P23771 (/ISS) P23825 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
Uterus development GO:0060065
The reproductive developmental process whose specific outcome is the progression of the uterus over time, from its formation to the mature structure.
8 D2HDE5 (/ISS) E2RPT1 (/ISS) P23771 (/ISS) P23825 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
Ureteric bud formation GO:0060676
The developmental process pertaining to the initial formation of the ureteric bud from the Wolffian duct. This process begins when the bud protrudes from the duct and ends when it is a recognizable bud.
8 D2HDE5 (/ISS) E2RPT1 (/ISS) P23771 (/ISS) P23825 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
Canonical Wnt signaling pathway involved in metanephric kidney development GO:0061290
The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes that contribute to the progression of the metanephric kidney over time. In this pathway, the activated receptor signals via downstream effectors that result in the inhibition of beta-catenin phosphorylation, thereby preventing degradation of beta-catenin. Stabilized beta-catenin can then accumulate and travel to the nucleus to trigger changes in transcription of target genes.
8 D2HDE5 (/ISS) E2RPT1 (/ISS) P23771 (/ISS) P23825 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
Positive regulation of ureteric bud formation GO:0072107
Any process that increases the rate or extent of the developmental process pertaining to the initial formation of the ureteric bud from the Wolffian duct.
8 D2HDE5 (/ISS) E2RPT1 (/ISS) P23771 (/ISS) P23825 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
Nephric duct morphogenesis GO:0072178
The process in which the anatomical structures of the nephric duct are generated and organized. A nephric duct is a tube that drains a primitive kidney.
8 D2HDE5 (/ISS) E2RPT1 (/ISS) P23771 (/ISS) P23825 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
Nephric duct formation GO:0072179
The developmental process pertaining to the initial formation of a nephric duct. A nephric duct is a tube that drains a primitive kidney.
8 D2HDE5 (/ISS) E2RPT1 (/ISS) P23771 (/ISS) P23825 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
Regulation of nephron tubule epithelial cell differentiation GO:0072182
Any process that modulates the frequency, rate or extent of nephron tubule epithelial cell differentiation.
8 D2HDE5 (/ISS) E2RPT1 (/ISS) P23771 (/ISS) P23825 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
Negative regulation of cell proliferation involved in mesonephros development GO:2000607
Any process that stops, prevents or reduces the frequency, rate or extent of cell proliferation involved in mesonephros development.
8 D2HDE5 (/ISS) E2RPT1 (/ISS) P23771 (/ISS) P23825 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
Negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation GO:2000703
Any process that stops, prevents or reduces the frequency, rate or extent of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation.
8 D2HDE5 (/ISS) E2RPT1 (/ISS) P23771 (/ISS) P23825 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
Negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation GO:2000734
Any process that stops, prevents or reduces the frequency, rate or extent of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation.
8 D2HDE5 (/ISS) E2RPT1 (/ISS) P23771 (/ISS) P23825 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
Negative regulation of transcription by RNA polymerase II GO:0000122
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
7 O09100 (/IDA) O09100 (/IDA) P15976 (/IDA) P17679 (/IDA) P23772 (/IDA) P23772 (/IDA) Q92908 (/IDA)
Kidney development GO:0001822
The process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and/or excretes the end products of body metabolism in the form of urine.
7 D2HDE5 (/ISS) E2RPT1 (/ISS) P23825 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
Heart morphogenesis GO:0003007
The developmental process in which the heart is generated and organized. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
7 A0A0R4IB15 (/IMP) Q08369 (/IMP) Q1JQ00 (/IMP) Q567K8 (/IMP) Q6NW63 (/IMP) Q9PTJ1 (/IMP) Q9W6U0 (/IMP)
Ventral spinal cord interneuron differentiation GO:0021514
The process in which neuroepithelial cells in the neural tube acquire specialized structural and/or functional features of ventral spinal cord interneurons. Ventral spinal cord interneurons are cells located in the ventral portion of the spinal cord that transmit signals between sensory and motor neurons and are required for reflexive responses. Differentiation includes the processes involved in commitment of a cell to a specific fate.
7 A0A2R9YJP8 (/IMP) O09100 (/IMP) O09100 (/IMP) Q7T3G1 (/IMP) Q90411 (/IMP) Q91428 (/IMP) Q91428 (/IMP)
Positive regulation of angiogenesis GO:0045766
Any process that activates or increases angiogenesis.
7 P23769 (/IDA) P23769 (/IDA) P23769 (/IDA) P23769 (/IDA) P23769 (/IDA) Q08369 (/IDA) Q92908 (/IDA)
Positive regulation of angiogenesis GO:0045766
Any process that activates or increases angiogenesis.
7 O09100 (/IMP) O09100 (/IMP) P23769 (/IMP) P23769 (/IMP) P23769 (/IMP) P23769 (/IMP) P23769 (/IMP)
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
7 I3LUZ9 (/IMP) P23771 (/IMP) P23772 (/IMP) P23772 (/IMP) P23825 (/IMP) Q8MIM5 (/IMP) Q92908 (/IMP)
Positive regulation of phagocytosis GO:0050766
Any process that activates or increases the frequency, rate or extent of phagocytosis.
7 O09100 (/ISS) O09100 (/ISS) P23769 (/ISS) P23769 (/ISS) P23769 (/ISS) P23769 (/ISS) P23769 (/ISS)
Regulation of hematopoietic stem cell differentiation GO:1902036
Any process that modulates the frequency, rate or extent of hematopoietic stem cell differentiation.
7 P15976 (/TAS) P23769 (/TAS) P23769 (/TAS) P23769 (/TAS) P23769 (/TAS) P23769 (/TAS) P23771 (/TAS)
Positive regulation of transcription regulatory region DNA binding GO:2000679
Any process that activates or increases the frequency, rate or extent of transcription regulatory region DNA binding.
7 D2HDE5 (/ISS) E2RPT1 (/ISS) P23825 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS)
Aortic valve morphogenesis GO:0003180
The process in which the structure of the aortic valve is generated and organized.
6 P23772 (/IMP) P23772 (/IMP) P43694 (/IMP) P43694 (/IMP) P97489 (/IMP) Q9BWX5 (/IMP)
Regulation of transcription, DNA-templated GO:0006355
Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription.
6 A0A0R4IB15 (/IDA) P46152 (/IDA) P97489 (/IDA) Q08369 (/IDA) Q6NW63 (/IDA) Q9PTJ1 (/IDA)
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
6 P23769 (/IMP) P23769 (/IMP) P23769 (/IMP) P23769 (/IMP) P23769 (/IMP) P97489 (/IMP)
Embryonic heart tube development GO:0035050
The process whose specific outcome is the progression of the embryonic heart tube over time, from its formation to the mature structure. The heart tube forms as the heart rudiment from the heart field.
6 A0A0R4ILP3 (/IMP) P52168 (/IMP) P52168 (/IMP) Q08369 (/IMP) Q09JY7 (/IMP) Q9PTJ2 (/IMP)
Eosinophil fate commitment GO:0035854
The process in which the developmental fate of a cell becomes restricted such that it will develop into a eosinophil cell. A eosinophil is any of the immature or mature forms of a granular leukocyte with a nucleus that usually has two lobes connected by one or more slender threads of chromatin, and cytoplasm containing coarse, round granules that are uniform in size and which can be stained by the dye eosin.
6 P15976 (/IDA) P23769 (/IDA) P23769 (/IDA) P23769 (/IDA) P23769 (/IDA) P23769 (/IDA)
Erythrocyte development GO:0048821
The process whose specific outcome is the progression of an erythrocyte over time, from its formation to the mature structure.
6 A0A2R9YJP8 (/IMP) P15976 (/IMP) Q05AJ3 (/IMP) Q7T3G1 (/IMP) Q90410 (/IMP) Q90411 (/IMP)
Negative regulation of endothelial cell apoptotic process GO:2000352
Any process that stops, prevents or reduces the frequency, rate or extent of endothelial cell apoptotic process.
6 P23769 (/IMP) P23769 (/IMP) P23769 (/IMP) P23769 (/IMP) P23769 (/IMP) P23771 (/IMP)
In utero embryonic development GO:0001701
The process whose specific outcome is the progression of the embryo in the uterus over time, from formation of the zygote in the oviduct, to birth. An example of this process is found in Mus musculus.
5 P17679 (/IMP) P23772 (/IMP) P23772 (/IMP) Q08369 (/IMP) Q61169 (/IMP)
Transcription, DNA-templated GO:0006351
The cellular synthesis of RNA on a template of DNA.
5 P23769 (/IDA) P23769 (/IDA) P23769 (/IDA) P23769 (/IDA) P23769 (/IDA)
Male gonad development GO:0008584
The process whose specific outcome is the progression of the male gonad over time, from its formation to the mature structure.
5 P15976 (/IMP) P23772 (/IMP) P23772 (/IMP) P43694 (/IMP) P43694 (/IMP)
Embryonic hemopoiesis GO:0035162
The stages of blood cell formation that take place within the embryo.
5 P17679 (/IMP) P23772 (/IMP) P23772 (/IMP) Q05AJ3 (/IMP) Q90410 (/IMP)
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
5 P15976 (/IMP) P17679 (/IMP) Q05AJ3 (/IMP) Q90410 (/IMP) Q92908 (/IMP)
Negative regulation of Notch signaling pathway GO:0045746
Any process that stops, prevents, or reduces the frequency, rate or extent of the Notch signaling pathway.
5 P23769 (/IDA) P23769 (/IDA) P23769 (/IDA) P23769 (/IDA) P23769 (/IDA)
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
5 P17679 (/ISO) P23772 (/ISO) P23772 (/ISO) Q08369 (/ISO) Q61169 (/ISO)
Thymus development GO:0048538
The process whose specific outcome is the progression of the thymus over time, from its formation to the mature structure. The thymus is a symmetric bi-lobed organ involved primarily in the differentiation of immature to mature T cells, with unique vascular, nervous, epithelial, and lymphoid cell components.
5 P23772 (/IMP) P23772 (/IMP) Q1JQ00 (/IMP) Q567K8 (/IMP) Q9W6U0 (/IMP)
Cardiac muscle cell differentiation GO:0055007
The process in which a cardiac muscle precursor cell acquires specialized features of a cardiac muscle cell. Cardiac muscle cells are striated muscle cells that are responsible for heart contraction.
5 Q08369 (/IGI) Q1JQ00 (/IGI) Q567K8 (/IGI) Q61169 (/IGI) Q9W6U0 (/IGI)
Cardiac muscle cell differentiation GO:0055007
The process in which a cardiac muscle precursor cell acquires specialized features of a cardiac muscle cell. Cardiac muscle cells are striated muscle cells that are responsible for heart contraction.
5 Q08369 (/IMP) Q1JQ00 (/IMP) Q567K8 (/IMP) Q61169 (/IMP) Q9W6U0 (/IMP)
Primitive hemopoiesis GO:0060215
A first transient wave of blood cell production that, in vertebrates, gives rise to erythrocytes (red blood cells) and myeloid cells.
5 A0A2R9YJP8 (/IGI) Q05AJ3 (/IGI) Q7T3G1 (/IGI) Q90410 (/IGI) Q90411 (/IGI)
Cardiac muscle tissue regeneration GO:0061026
The regrowth of cardiac muscle tissue to repair injured or damaged muscle fibers in the postnatal stage.
5 A0A0R4ILP3 (/IMP) Q09JY7 (/IMP) Q91428 (/IMP) Q91428 (/IMP) Q9PTJ2 (/IMP)
Negative regulation of fat cell proliferation GO:0070345
Any process that stops or decreases the rate or extent of fat cell proliferation.
5 P23769 (/IMP) P23769 (/IMP) P23769 (/IMP) P23769 (/IMP) P23769 (/IMP)
Positive regulation of cell migration involved in sprouting angiogenesis GO:0090050
Any process that increases the frequency, rate or extent of cell migration involved in sprouting angiogenesis. Cell migration involved in sprouting angiogenesis is the orderly movement of endothelial cells into the extracellular matrix in order to form new blood vessels contributing to the process of sprouting angiogenesis.
5 P23769 (/IMP) P23769 (/IMP) P23769 (/IMP) P23769 (/IMP) P23769 (/IMP)
Positive regulation of pri-miRNA transcription by RNA polymerase II GO:1902895
Any process that activates or increases the frequency, rate or extent of pri-miRNA transcription mediated by RNA polymerase II.
5 P23769 (/IDA) P23769 (/IDA) P23769 (/IDA) P23769 (/IDA) P23769 (/IDA)
Positive regulation of pri-miRNA transcription by RNA polymerase II GO:1902895
Any process that activates or increases the frequency, rate or extent of pri-miRNA transcription mediated by RNA polymerase II.
5 P23769 (/IGI) P23769 (/IGI) P23769 (/IGI) P23769 (/IGI) P23769 (/IGI)
Positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis GO:1903589
Any process that activates or increases the frequency, rate or extent of blood vessel endothelial cell proliferation involved in sprouting angiogenesis.
5 P23769 (/IMP) P23769 (/IMP) P23769 (/IMP) P23769 (/IMP) P23769 (/IMP)
Negative regulation of neural precursor cell proliferation GO:2000178
Any process that stops, prevents, or reduces the frequency, rate or extent of neural precursor cell proliferation.
5 P23769 (/IDA) P23769 (/IDA) P23769 (/IDA) P23769 (/IDA) P23769 (/IDA)
Endoderm formation GO:0001706
The formation of the endoderm during gastrulation.
4 Q08369 (/IMP) Q1JQ00 (/IMP) Q567K8 (/IMP) Q9W6U0 (/IMP)
Cell fate determination GO:0001709
A process involved in cell fate commitment. Once determination has taken place, a cell becomes committed to differentiate down a particular pathway regardless of its environment.
4 O09100 (/IDA) O09100 (/IDA) P23772 (/IDA) P23772 (/IDA)
Neuron migration GO:0001764
The characteristic movement of an immature neuron from germinal zones to specific positions where they will reside as they mature.
4 P23772 (/IMP) P23772 (/IMP) Q924Y4 (/IMP) Q924Y4 (/IMP)
Heart development GO:0007507
The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
4 Q08369 (/IMP) Q1JQ00 (/IMP) Q567K8 (/IMP) Q9W6U0 (/IMP)
Regulation of gene expression GO:0010468
Any process that modulates the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
4 Q08369 (/IDA) Q1JQ00 (/IDA) Q567K8 (/IDA) Q9W6U0 (/IDA)
Neuron differentiation GO:0030182
The process in which a relatively unspecialized cell acquires specialized features of a neuron.
4 O09100 (/IMP) O09100 (/IMP) P23772 (/IMP) P23772 (/IMP)
Pancreas development GO:0031016
The process whose specific outcome is the progression of the pancreas over time, from its formation to the mature structure. The pancreas is an endoderm derived structure that produces precursors of digestive enzymes and blood glucose regulating enzymes.
4 Q1JQ00 (/IMP) Q567K8 (/IMP) Q61169 (/IMP) Q9W6U0 (/IMP)
Inner ear morphogenesis GO:0042472
The process in which the anatomical structures of the inner ear are generated and organized. The inner ear is the structure in vertebrates that contains the organs of balance and hearing. It consists of soft hollow sensory structures (the membranous labyrinth) containing fluid (endolymph) surrounded by fluid (perilymph) and encased in a bony cavity (the bony labyrinth). It consists of two chambers, the sacculus and utriculus, from which arise the cochlea and semicircular canals respectively.
4 O09100 (/IMP) O09100 (/IMP) P23772 (/IMP) P23772 (/IMP)
Negative regulation of fat cell differentiation GO:0045599
Any process that stops, prevents, or reduces the frequency, rate or extent of adipocyte differentiation.
4 O09100 (/ISO) O09100 (/ISO) P23772 (/ISO) P23772 (/ISO)
Cell maturation GO:0048469
A developmental process, independent of morphogenetic (shape) change, that is required for a cell to attain its fully functional state.
4 O09100 (/IMP) O09100 (/IMP) P23772 (/IMP) P23772 (/IMP)
Definitive hemopoiesis GO:0060216
A second wave of blood cell production that, in vertebrates, generates long-term hemopoietic stem cells that continously provide erythroid, myeloid and lymphoid lineages throughout adulthood.
4 F1QD30 (/IMP) O09100 (/IMP) O09100 (/IMP) Q6DG89 (/IMP)
Intestinal epithelial cell differentiation GO:0060575
The process in which a relatively unspecialized cell acquires specialized features of a columnar/cuboidal epithelial cell of the intestine.
4 P43694 (/IDA) P43694 (/IDA) Q92908 (/IDA) Q9BWX5 (/IDA)
Cellular response to BMP stimulus GO:0071773
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a bone morphogenetic protein (BMP) stimulus.
4 P23772 (/IDA) P23772 (/IDA) P97489 (/IDA) Q61169 (/IDA)
Negative regulation of endothelial cell apoptotic process GO:2000352
Any process that stops, prevents or reduces the frequency, rate or extent of endothelial cell apoptotic process.
4 O09100 (/ISO) O09100 (/ISO) P23772 (/ISO) P23772 (/ISO)
Endoderm formation GO:0001706
The formation of the endoderm during gastrulation.
3 Q1JQ00 (/IGI) Q567K8 (/IGI) Q9W6U0 (/IGI)
Heart looping GO:0001947
The tube morphogenesis process in which the primitive heart tube loops asymmetrically. This looping brings the primitive heart chambers into alignment preceding their future integration. Heart looping begins with dextral-looping and ends when the main regional divisions of the mature heart and primordium of the great arterial trunks become established preceeding septation.
3 A0A0R4ILP3 (/IGI) Q09JY7 (/IGI) Q9PTJ2 (/IGI)
Heart morphogenesis GO:0003007
The developmental process in which the heart is generated and organized. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
3 Q1JQ00 (/IGI) Q567K8 (/IGI) Q9W6U0 (/IGI)
Embryonic heart tube morphogenesis GO:0003143
The process in which the anatomical structures of the embryonic heart tube are generated and organized. The embryonic heart tube is an epithelial tube that will give rise to the mature heart.
3 Q1JQ00 (/IMP) Q567K8 (/IMP) Q9W6U0 (/IMP)
Atrioventricular valve formation GO:0003190
The developmental process pertaining to the initial formation of the atrioventricular valve from unspecified parts. This process begins with the specific processes that contribute to the appearance of the discrete structure and ends when the structural rudiment is recognizable.
3 A0A2R9YJP8 (/IMP) Q7T3G1 (/IMP) Q90411 (/IMP)
Endocardial cushion development GO:0003197
The progression of a cardiac cushion over time, from its initial formation to the mature structure. The endocardial cushion is a specialized region of mesenchymal cells that will give rise to the heart septa and valves.
3 P43694 (/IMP) P43694 (/IMP) Q08369 (/IMP)
Cardiac right ventricle morphogenesis GO:0003215
The process in which the right cardiac ventricle is generated and organized.
3 P23772 (/IMP) P23772 (/IMP) Q08369 (/IMP)
Ventricular septum development GO:0003281
The progression of the ventricular septum over time from its formation to the mature structure.
3 P23772 (/IMP) P23772 (/IMP) Q08369 (/IMP)
Regulation of transcription by RNA polymerase II GO:0006357
Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II.
3 P23772 (/IDA) P23772 (/IDA) Q08369 (/IDA)
Positive regulation of cytosolic calcium ion concentration GO:0007204
Any process that increases the concentration of calcium ions in the cytosol.
3 P43429 (/IMP) Q924Y4 (/IMP) Q924Y4 (/IMP)
Endoderm development GO:0007492
The process whose specific outcome is the progression of the endoderm over time, from its formation to the mature structure. The endoderm is the innermost germ layer that develops into the gastrointestinal tract, the lungs and associated tissues.
3 Q1JQ00 (/IMP) Q567K8 (/IMP) Q9W6U0 (/IMP)
Heart development GO:0007507
The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
3 A0A0R4ILP3 (/IGI) Q09JY7 (/IGI) Q9PTJ2 (/IGI)
Heart development GO:0007507
The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
3 P46152 (/TAS) P52168 (/TAS) P52168 (/TAS)
Negative regulation of cell population proliferation GO:0008285
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
3 P17679 (/IMP) P23772 (/IMP) P23772 (/IMP)
Male gonad development GO:0008584
The process whose specific outcome is the progression of the male gonad over time, from its formation to the mature structure.
3 P43694 (/IEP) P43694 (/IEP) Q92908 (/IEP)
Regulation of primitive erythrocyte differentiation GO:0010725
Any process that modulates the rate, frequency, or extent of primitive erythrocyte differentiation. Primitive erythrocyte differentiation occurs as part of the process of primitive hemopoiesis.
3 O09100 (/IGI) O09100 (/IGI) P17679 (/IGI)
Erythrocyte differentiation GO:0030218
The process in which a myeloid precursor cell acquires specializes features of an erythrocyte.
3 P17679 (/IDA) P23772 (/IDA) P23772 (/IDA)
Erythrocyte differentiation GO:0030218
The process in which a myeloid precursor cell acquires specializes features of an erythrocyte.
3 P17679 (/IMP) Q05AJ3 (/IMP) Q90410 (/IMP)
Thyroid gland development GO:0030878
The process whose specific outcome is the progression of the thyroid gland over time, from its formation to the mature structure. The thyroid gland is an endoderm-derived gland that produces thyroid hormone.
3 Q1JQ00 (/IMP) Q567K8 (/IMP) Q9W6U0 (/IMP)
Cardiocyte differentiation GO:0035051
The process in which a relatively unspecialized cell acquires the specialized structural and/or functional features of a cell that will form part of the cardiac organ of an individual.
3 P52168 (/IMP) P52168 (/IMP) P70005 (/IMP)
Eosinophil fate commitment GO:0035854
The process in which the developmental fate of a cell becomes restricted such that it will develop into a eosinophil cell. A eosinophil is any of the immature or mature forms of a granular leukocyte with a nucleus that usually has two lobes connected by one or more slender threads of chromatin, and cytoplasm containing coarse, round granules that are uniform in size and which can be stained by the dye eosin.
3 O09100 (/ISO) O09100 (/ISO) P17679 (/ISO)
Dorsal aorta morphogenesis GO:0035912
The process in which the anatomical structures of the dorsal aorta are generated and organized. The dorsal aorta is a blood vessel in a single-pass circulatory system that carries oxygenated blood from the gills to the rest of the body. In a single-pass circulatory system blood passes once through the heart to supply the body once.
3 A0A2R9YJP8 (/IMP) Q7T3G1 (/IMP) Q90411 (/IMP)
Response to drug GO:0042493
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
3 P43694 (/IMP) P43694 (/IMP) Q92908 (/IMP)
Positive regulation of mast cell degranulation GO:0043306
Any process that activates or increases the frequency, rate or extent of mast cell degranulation.
3 P43429 (/IMP) Q924Y4 (/IMP) Q924Y4 (/IMP)
Positive regulation of angiogenesis GO:0045766
Any process that activates or increases angiogenesis.
3 O09100 (/ISO) O09100 (/ISO) Q61169 (/ISO)
Negative regulation of cell cycle GO:0045786
Any process that stops, prevents or reduces the rate or extent of progression through the cell cycle.
3 P23771 (/IMP) P23772 (/IMP) P23772 (/IMP)
Negative regulation of transcription, DNA-templated GO:0045892
Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.
3 P23772 (/ISO) P23772 (/ISO) Q61169 (/ISO)
Digestive tract development GO:0048565
The process whose specific outcome is the progression of the digestive tract over time, from its formation to the mature structure. The digestive tract is the anatomical structure through which food passes and is processed.
3 A0A0R4IB15 (/IMP) Q6NW63 (/IMP) Q9PTJ1 (/IMP)
Post-embryonic foregut morphogenesis GO:0048618
The process in which the anatomical structures of the foregut are generated and organized, during the post-embryonic phase.
3 Q1JQ00 (/IMP) Q567K8 (/IMP) Q9W6U0 (/IMP)
Swim bladder formation GO:0048797
The process that gives rise to the swim bladder. This process pertains to the initial formation of a structure from unspecified parts. The swim bladder is used by some fishes to maintain buoyancy and may function in addition as a sound producing organ, a sound receptor, and a respiratory organ.
3 A0A0R4ILP3 (/IGI) Q09JY7 (/IGI) Q9PTJ2 (/IGI)
Homeostasis of number of cells within a tissue GO:0048873
Any biological process involved in the maintenance of the steady-state number of cells within a population of cells in a tissue.
3 O09100 (/IGI) O09100 (/IGI) P17679 (/IGI)
Cardiac muscle cell differentiation GO:0055007
The process in which a cardiac muscle precursor cell acquires specialized features of a cardiac muscle cell. Cardiac muscle cells are striated muscle cells that are responsible for heart contraction.
3 P46152 (/IEP) Q08369 (/IEP) Q61169 (/IEP)
Ventricular cardiac muscle tissue morphogenesis GO:0055010
The process in which the anatomical structures of cardiac ventricle muscle is generated and organized.
3 A0A0R4ILP3 (/IMP) Q09JY7 (/IMP) Q9PTJ2 (/IMP)
Intestinal epithelial cell differentiation GO:0060575
The process in which a relatively unspecialized cell acquires specialized features of a columnar/cuboidal epithelial cell of the intestine.
3 P97489 (/ISO) Q08369 (/ISO) Q61169 (/ISO)
Left/right pattern formation GO:0060972
The pattern specification process that results in the subdivision of the left/right axis in space to define an area or volume in which specific patterns of cell differentiation will take place or in which cells interpret a specific environment.
3 Q1JQ00 (/IMP) Q567K8 (/IMP) Q9W6U0 (/IMP)
Kupffer's vesicle development GO:0070121
The progression of the Kupffer's vesicle over time from its initial formation until its mature state. The Kupffer's vesicle is a small but distinctive epithelial sac containing fluid, located midventrally posterior to the yolk cell or its extension, and transiently present during most of the segmentation period.
3 Q1JQ00 (/IMP) Q567K8 (/IMP) Q9W6U0 (/IMP)
Cellular response to interleukin-4 GO:0071353
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-4 stimulus.
3 P23771 (/IEP) P23772 (/IEP) P23772 (/IEP)
Cochlea development GO:0090102
The progression of the cochlea over time from its formation to the mature structure. The cochlea is the snail-shaped portion of the inner ear that is responsible for the detection of sound.
3 Q924Y4 (/IEP) Q924Y4 (/IEP) Q99NH5 (/IEP)
Positive regulation of transcription regulatory region DNA binding GO:2000679
Any process that activates or increases the frequency, rate or extent of transcription regulatory region DNA binding.
3 P23771 (/IMP) P23772 (/IMP) P23772 (/IMP)
Negative regulation of transcription by RNA polymerase II GO:0000122
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
2 P52168 (/IMP) P52168 (/IMP)
Negative regulation of transcription by RNA polymerase II GO:0000122
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
2 P17679 (/ISO) Q61169 (/ISO)
Cell morphogenesis GO:0000902
The developmental process in which the size or shape of a cell is generated and organized.
2 P23772 (/IMP) P23772 (/IMP)
Urogenital system development GO:0001655
The process whose specific outcome is the progression of the urogenital system over time, from its formation to the mature structure.
2 O09100 (/IMP) O09100 (/IMP)
Neuron migration GO:0001764
The characteristic movement of an immature neuron from germinal zones to specific positions where they will reside as they mature.
2 O09100 (/ISO) O09100 (/ISO)
Cell activation GO:0001775
A change in the morphology or behavior of a cell resulting from exposure to an activating factor such as a cellular or soluble ligand.
2 P23772 (/IMP) P23772 (/IMP)
Positive regulation of cytokine production GO:0001819
Any process that activates or increases the frequency, rate or extent of production of a cytokine.
2 P23772 (/IDA) P23772 (/IDA)
Kidney development GO:0001822
The process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and/or excretes the end products of body metabolism in the form of urine.
2 P23772 (/ISO) P23772 (/ISO)
Mesonephros development GO:0001823
The process whose specific outcome is the progression of the mesonephros over time, from its formation to the mature structure. In mammals, the mesonephros is the second of the three embryonic kidneys to be established and exists only transiently. In lower vertebrates such as fish and amphibia, the mesonephros will form the mature kidney.
2 P23772 (/IMP) P23772 (/IMP)
Embryonic placenta development GO:0001892
The embryonically driven process whose specific outcome is the progression of the placenta over time, from its formation to the mature structure. The placenta is an organ of metabolic interchange between fetus and mother, partly of embryonic origin and partly of maternal origin.
2 O09100 (/IMP) O09100 (/IMP)
Heart looping GO:0001947
The tube morphogenesis process in which the primitive heart tube loops asymmetrically. This looping brings the primitive heart chambers into alignment preceding their future integration. Heart looping begins with dextral-looping and ends when the main regional divisions of the mature heart and primordium of the great arterial trunks become established preceeding septation.
2 P43694 (/ISS) P43694 (/ISS)
Lens development in camera-type eye GO:0002088
The process whose specific outcome is the progression of the lens over time, from its formation to the mature structure. The lens is a transparent structure in the eye through which light is focused onto the retina. An example of this process is found in Mus musculus.
2 P23772 (/IMP) P23772 (/IMP)
Pro-T cell differentiation GO:0002572
The process in which a precursor cell type acquires the specialized features of a pro-T cell. Pro-T cells are the earliest stage of the T cell lineage but are not fully committed.
2 P23772 (/IMP) P23772 (/IMP)
Aortic valve morphogenesis GO:0003180
The process in which the structure of the aortic valve is generated and organized.
2 P97489 (/ISO) Q08369 (/ISO)
Atrioventricular valve formation GO:0003190
The developmental process pertaining to the initial formation of the atrioventricular valve from unspecified parts. This process begins with the specific processes that contribute to the appearance of the discrete structure and ends when the structural rudiment is recognizable.
2 P43694 (/ISS) P43694 (/ISS)
Endocardial cushion development GO:0003197
The progression of a cardiac cushion over time, from its initial formation to the mature structure. The endocardial cushion is a specialized region of mesenchymal cells that will give rise to the heart septa and valves.
2 P43694 (/ISS) P43694 (/ISS)
Cardiac ventricle morphogenesis GO:0003208
The process in which the cardiac ventricle is generated and organized. A cardiac ventricle receives blood from a cardiac atrium and pumps it out of the heart.
2 P43694 (/TAS) P43694 (/TAS)
Atrial septum primum morphogenesis GO:0003289
The process in which anatomical structure of an atrial septum primum is generated and organized.
2 P43694 (/ISS) P43694 (/ISS)
Atrial septum secundum morphogenesis GO:0003290
The process in which anatomical structure of an atrial septum secundum is generated and organized.
2 P43694 (/IMP) P43694 (/IMP)
Chromatin remodeling GO:0006338
Dynamic structural changes to eukaryotic chromatin occurring throughout the cell division cycle. These changes range from the local changes necessary for transcriptional regulation to global changes necessary for chromosome segregation.
2 P23772 (/IDA) P23772 (/IDA)
Chromatin remodeling GO:0006338
Dynamic structural changes to eukaryotic chromatin occurring throughout the cell division cycle. These changes range from the local changes necessary for transcriptional regulation to global changes necessary for chromosome segregation.
2 P23772 (/IMP) P23772 (/IMP)
Transcription, DNA-templated GO:0006351
The cellular synthesis of RNA on a template of DNA.
2 P52168 (/IGI) P52168 (/IGI)
Transcription, DNA-templated GO:0006351
The cellular synthesis of RNA on a template of DNA.
2 O09100 (/ISO) O09100 (/ISO)
Regulation of transcription, DNA-templated GO:0006355
Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription.
2 P43694 (/ISS) P43694 (/ISS)
Regulation of transcription, DNA-templated GO:0006355
Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription.
2 P43429 (/TAS) Q08369 (/TAS)
Regulation of transcription by RNA polymerase II GO:0006357
Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II.
2 P23772 (/IGI) P23772 (/IGI)
Regulation of transcription by RNA polymerase II GO:0006357
Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II.
2 P23772 (/IMP) P23772 (/IMP)
Transcription by RNA polymerase II GO:0006366
The synthesis of RNA from a DNA template by RNA polymerase II (RNAP II), originating at an RNA polymerase II promoter. Includes transcription of messenger RNA (mRNA) and certain small nuclear RNAs (snRNAs).
2 P15976 (/IDA) Q92908 (/IDA)
Transcription by RNA polymerase II GO:0006366
The synthesis of RNA from a DNA template by RNA polymerase II (RNAP II), originating at an RNA polymerase II promoter. Includes transcription of messenger RNA (mRNA) and certain small nuclear RNAs (snRNAs).
2 P17679 (/ISO) Q61169 (/ISO)
Humoral immune response GO:0006959
An immune response mediated through a body fluid.
2 P23772 (/IMP) P23772 (/IMP)
Positive regulation of antibacterial peptide biosynthetic process GO:0006963
Any process that activates or increases the frequency, rate, or extent of antibacterial peptide biosynthesis.
2 P52168 (/IMP) P52168 (/IMP)
Signal transduction GO:0007165
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
2 P23772 (/IMP) P23772 (/IMP)
Positive regulation of cytosolic calcium ion concentration GO:0007204
Any process that increases the concentration of calcium ions in the cytosol.
2 O09100 (/ISO) O09100 (/ISO)
Cell-cell signaling GO:0007267
Any process that mediates the transfer of information from one cell to another. This process includes signal transduction in the receiving cell and, where applicable, release of a ligand and any processes that actively facilitate its transport and presentation to the receiving cell. Examples include signaling via soluble ligands, via cell adhesion molecules and via gap junctions.
2 P17679 (/IMP) Q08369 (/IMP)
Cell-cell signaling GO:0007267
Any process that mediates the transfer of information from one cell to another. This process includes signal transduction in the receiving cell and, where applicable, release of a ligand and any processes that actively facilitate its transport and presentation to the receiving cell. Examples include signaling via soluble ligands, via cell adhesion molecules and via gap junctions.
2 P43694 (/ISS) P43694 (/ISS)
Blastoderm segmentation GO:0007350
The hierarchical steps resulting in the progressive subdivision of the anterior/posterior axis of the embryo.
2 P52168 (/IMP) P52168 (/IMP)
Pattern specification process GO:0007389
Any developmental process that results in the creation of defined areas or spaces within an organism to which cells respond and eventually are instructed to differentiate.
2 P52168 (/NAS) P52168 (/NAS)
Dorsal closure GO:0007391
The process during Drosophila embryogenesis whereby the ectodermal cells of the lateral epithelium stretch in a coordinated fashion to internalize the amnioserosa cells and close the embryo dorsally.
2 P52168 (/TAS) P52168 (/TAS)
Ectoderm development GO:0007398
The process whose specific outcome is the progression of the ectoderm over time, from its formation to the mature structure. In animal embryos, the ectoderm is the outer germ layer of the embryo, formed during gastrulation.
2 P52168 (/TAS) P52168 (/TAS)
Nervous system development GO:0007399
The process whose specific outcome is the progression of nervous tissue over time, from its formation to its mature state.
2 P23772 (/IMP) P23772 (/IMP)
Axon guidance GO:0007411
The chemotaxis process that directs the migration of an axon growth cone to a specific target site in response to a combination of attractive and repulsive cues.
2 P23772 (/IMP) P23772 (/IMP)
Endoderm development GO:0007492
The process whose specific outcome is the progression of the endoderm over time, from its formation to the mature structure. The endoderm is the innermost germ layer that develops into the gastrointestinal tract, the lungs and associated tissues.
2 P43694 (/TAS) P43694 (/TAS)
Cardioblast cell fate determination GO:0007510
The cell fate determination process in which a cell becomes capable of differentiating autonomously into a cardioblast cell regardless of its environment; upon determination, the cell fate cannot be reversed. A cardioblast is a cardiac precursor cell. It is a cell that has been committed to a cardiac fate, but will undergo more cell division rather than terminally differentiating.
2 P52168 (/IMP) P52168 (/IMP)
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
2 Q91428 (/IMP) Q91428 (/IMP)
Chaeta morphogenesis GO:0008407
The process in which the anatomical structures of the chaeta are generated and organized. A chaeta is a sensory multicellular cuticular outgrowth of a specifically differentiated cell.
2 P52168 (/TAS) P52168 (/TAS)
Fibroblast growth factor receptor signaling pathway GO:0008543
The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands.
2 Q91428 (/IDA) Q91428 (/IDA)
Male gonad development GO:0008584
The process whose specific outcome is the progression of the male gonad over time, from its formation to the mature structure.
2 P17679 (/ISO) Q08369 (/ISO)
Post-embryonic development GO:0009791
The process whose specific outcome is the progression of the organism over time, from the completion of embryonic development to the mature structure. See embryonic development.
2 P23772 (/IMP) P23772 (/IMP)
Positive regulation of signal transduction GO:0009967
Any process that activates or increases the frequency, rate or extent of signal transduction.
2 P23772 (/ISO) P23772 (/ISO)
Cardioblast differentiation GO:0010002
The process in which a relatively unspecialized mesodermal cell acquires the specialized structural and/or functional features of a cardioblast. A cardioblast is a cardiac precursor cell. It is a cell that has been committed to a cardiac fate, but will undergo more cell division rather than terminally differentiating.
2 P52168 (/IMP) P52168 (/IMP)
Regulation of gene expression GO:0010468
Any process that modulates the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
2 Q08369 (/IGI) Q61169 (/IGI)
Regulation of glycoprotein biosynthetic process GO:0010559
Any process that modulates the rate, frequency, or extent of the chemical reactions and pathways resulting in the formation of glycoproteins, any protein that contains covalently bound glycose (i.e. monosaccharide) residues; the glycose occurs most commonly as oligosaccharide or fairly small polysaccharide but occasionally as monosaccharide.
2 P15976 (/IMP) P17679 (/IMP)
Positive regulation of vascular endothelial growth factor production GO:0010575
Any process that increases or activates the frequency, rate, or extent of production of vascular endothelial growth factor.
2 P43694 (/ISS) P43694 (/ISS)
Positive regulation of endothelial cell migration GO:0010595
Any process that increases the rate, frequency, or extent of the orderly movement of an endothelial cell into the extracellular matrix to form an endothelium.
2 P23772 (/ISO) P23772 (/ISO)
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
2 P23772 (/IGI) P23772 (/IGI)
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
2 O09100 (/ISO) O09100 (/ISO)
Negative regulation of gene expression GO:0010629
Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
2 Q05AJ3 (/IGI) Q90410 (/IGI)
Negative regulation of gene expression GO:0010629
Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
2 O09100 (/ISO) O09100 (/ISO)
Negative regulation of cardiac muscle cell apoptotic process GO:0010667
Any process that decreases the rate or extent of cardiac cell apoptotic process, a form of programmed cell death induced by external or internal signals that trigger the activity of proteolytic caspases whose actions dismantle a cardiac muscle cell and result in its death.
2 P43694 (/ISS) P43694 (/ISS)
Regulation of definitive erythrocyte differentiation GO:0010724
Any process that modulates the rate, frequency, or extent of definitive erythrocyte differentiation. Definitive erythrocyte differentiation occurs as part of the process of definitive hemopoiesis.
2 P15976 (/IDA) P17679 (/IDA)
Regulation of neuron projection development GO:0010975
Any process that modulates the rate, frequency or extent of neuron projection development. Neuron projection development is the process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites).
2 P23772 (/IMP) P23772 (/IMP)
Phosphatidylinositol 3-kinase signaling GO:0014065
A series of reactions within the signal-receiving cell, mediated by the intracellular phosphatidylinositol 3-kinase (PI3K). Many cell surface receptor linked signaling pathways signal through PI3K to regulate numerous cellular functions.
2 P23772 (/IMP) P23772 (/IMP)
Cardiac muscle hypertrophy in response to stress GO:0014898
The physiological enlargement or overgrowth of all or part of the heart muscle due to an increase in size (not length) of individual cardiac muscle fibers, without cell division, as a result of a disturbance in organismal or cellular homeostasis.
2 Q08369 (/IMP) Q61169 (/IMP)
Cell differentiation in hindbrain GO:0021533
The process in which relatively unspecialized cells acquire specialized structural and/or functional features that characterize the mature cells of the hindbrain. Differentiation includes the processes involved in commitment of a cell to a specific fate.
2 O09100 (/IMP) O09100 (/IMP)
Commitment of neuronal cell to specific neuron type in forebrain GO:0021902
The commitment of neuronal precursor cells to become specialized types of neurons in the forebrain.
2 O09100 (/IMP) O09100 (/IMP)
Central nervous system neuron development GO:0021954
The process whose specific outcome is the progression of a neuron whose cell body is located in the central nervous system, from initial commitment of the cell to a neuronal fate, to the fully functional differentiated neuron.
2 O09100 (/IMP) O09100 (/IMP)
Pituitary gland development GO:0021983
The progression of the pituitary gland over time from its initial formation until its mature state. The pituitary gland is an endocrine gland that secretes hormones that regulate many other glands.
2 O09100 (/IMP) O09100 (/IMP)
Chaeta development GO:0022416
The process whose specific outcome is the progression of a chaeta over time, from its formation to the mature structure. A chaeta is a sensory multicellular cuticular outgrowth of a specifically differentiated cell.
2 P52168 (/IGI) P52168 (/IGI)
Cell differentiation GO:0030154
The process in which relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state.
2 O09100 (/IMP) O09100 (/IMP)
Cell differentiation GO:0030154
The process in which relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state.
2 P52168 (/NAS) P52168 (/NAS)
T cell differentiation GO:0030217
The process in which a precursor cell type acquires characteristics of a more mature T-cell. A T cell is a type of lymphocyte whose definin characteristic is the expression of a T cell receptor complex.
2 P23772 (/IDA) P23772 (/IDA)
T cell differentiation GO:0030217
The process in which a precursor cell type acquires characteristics of a more mature T-cell. A T cell is a type of lymphocyte whose definin characteristic is the expression of a T cell receptor complex.
2 P23772 (/ISO) P23772 (/ISO)
Erythrocyte differentiation GO:0030218
The process in which a myeloid precursor cell acquires specializes features of an erythrocyte.
2 P17679 (/IGI) P23767 (/IGI)
Megakaryocyte differentiation GO:0030219
The process in which a myeloid precursor cell acquires specializes features of a megakaryocyte.
2 P15976 (/IMP) P17679 (/IMP)
Platelet formation GO:0030220
The process in which platelets bud from long processes extended by megakaryocytes.
2 P15976 (/IMP) P17679 (/IMP)
Neutrophil differentiation GO:0030223
The process in which a myeloid precursor cell acquires the specialized features of a neutrophil.
2 Q05AJ3 (/IMP) Q90410 (/IMP)
Monocyte differentiation GO:0030224
The process in which a relatively unspecialized myeloid precursor cell acquires the specialized features of a monocyte.
2 Q05AJ3 (/IMP) Q90410 (/IMP)
Macrophage differentiation GO:0030225
The process in which a relatively unspecialized monocyte acquires the specialized features of a macrophage.
2 Q05AJ3 (/IMP) Q90410 (/IMP)
Positive regulation of BMP signaling pathway GO:0030513
Any process that activates or increases the frequency, rate or extent of BMP signaling pathway activity.
2 P46152 (/IDA) P46153 (/IDA)
Positive regulation of BMP signaling pathway GO:0030513
Any process that activates or increases the frequency, rate or extent of BMP signaling pathway activity.
2 Q08369 (/ISO) Q61169 (/ISO)
Fin regeneration GO:0031101
The regrowth of fin tissue following its loss or destruction.
2 Q91428 (/IMP) Q91428 (/IMP)
TOR signaling GO:0031929
A series of molecular signals mediated by TOR (Target of rapamycin) proteins, members of the phosphoinositide (PI) 3-kinase related kinase (PIKK) family that act as serine/threonine kinases in response to nutrient availability or growth factors.
2 P23772 (/IMP) P23772 (/IMP)
Negative regulation of interferon-gamma production GO:0032689
Any process that stops, prevents, or reduces the frequency, rate, or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon.
2 P23772 (/IDA) P23772 (/IDA)
Negative regulation of interferon-gamma production GO:0032689
Any process that stops, prevents, or reduces the frequency, rate, or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon.
2 P23772 (/IMP) P23772 (/IMP)
Negative regulation of interleukin-2 production GO:0032703
Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-2 production.
2 P23772 (/IDA) P23772 (/IDA)
Positive regulation of interleukin-13 production GO:0032736
Any process that activates or increases the frequency, rate, or extent of interleukin-13 production.
2 P23772 (/IMP) P23772 (/IMP)
Positive regulation of interleukin-4 production GO:0032753
Any process that activates or increases the frequency, rate, or extent of interleukin-4 production.
2 P23772 (/IDA) P23772 (/IDA)
Positive regulation of interleukin-4 production GO:0032753
Any process that activates or increases the frequency, rate, or extent of interleukin-4 production.
2 P23772 (/IMP) P23772 (/IMP)
Positive regulation of interleukin-5 production GO:0032754
Any process that activates or increases the frequency, rate, or extent of interleukin-5 production.
2 P23772 (/IMP) P23772 (/IMP)
T cell differentiation in thymus GO:0033077
The process in which a precursor cell type acquires the specialized features of a T cell via a differentiation pathway dependent upon transit through the thymus.
2 P23772 (/IGI) P23772 (/IGI)
T cell differentiation in thymus GO:0033077
The process in which a precursor cell type acquires the specialized features of a T cell via a differentiation pathway dependent upon transit through the thymus.
2 P23772 (/IMP) P23772 (/IMP)
Negative regulation of mammary gland epithelial cell proliferation GO:0033600
Any process that stops, prevents or reduces the rate or extent of mammary gland epithelial cell proliferation.
2 P23772 (/ISO) P23772 (/ISO)
Response to lipid GO:0033993
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipid stimulus.
2 Q924Y4 (/IEP) Q924Y4 (/IEP)
Somatic stem cell population maintenance GO:0035019
Any process by which an organism retains a population of somatic stem cells, undifferentiated cells in the embryo or adult which can undergo unlimited division and give rise to cell types of the body other than those of the germ-line.
2 O09100 (/IMP) O09100 (/IMP)
Embryonic heart tube anterior/posterior pattern specification GO:0035054
The establishment, maintenance and elaboration of cell differentiation that results in the anterior/posterior subdivision of the embryonic heart tube. In Drosophila this results in subdivision of the dorsal vessel into to the posterior heart proper and the anterior aorta.
2 P43694 (/ISS) P43694 (/ISS)
Regulation of histone acetylation GO:0035065
Any process that modulates the frequency, rate or extent of the addition of an acetyl group to a histone protein.
2 O09100 (/IDA) O09100 (/IDA)
Embryonic hemopoiesis GO:0035162
The stages of blood cell formation that take place within the embryo.
2 P23772 (/IGI) P23772 (/IGI)
Tube morphogenesis GO:0035239
The process in which the anatomical structures of a tube are generated and organized. Epithelial and endothelial tubes transport gases, liquids and cells from one site to another and form the basic structure of many organs and tissues, with tube shape and organization varying from the single-celled excretory organ in Caenorhabditis elegans to the branching trees of the mammalian kidney and insect tracheal system.
2 Q08369 (/IGI) Q61169 (/IGI)
Ureter maturation GO:0035799
A developmental process, independent of morphogenetic (shape) change, that is required for the ureter to attain its fully functional state. The ureter is a muscular tube that transports urine from the kidney to the urinary bladder or from the Malpighian tubule to the hindgut.
2 P23772 (/IMP) P23772 (/IMP)
Parathyroid hormone secretion GO:0035898
The regulated release of parathyroid hormone into the circulatory system.
2 P23772 (/IMP) P23772 (/IMP)
Regulation of cytokine biosynthetic process GO:0042035
Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of cytokines.
2 P23772 (/IDA) P23772 (/IDA)
Tissue regeneration GO:0042246
The regrowth of lost or destroyed tissues.
2 Q91428 (/IMP) Q91428 (/IMP)
Norepinephrine biosynthetic process GO:0042421
The chemical reactions and pathways resulting in the formation of norepinephrine, a hormone secreted by the adrenal medulla, and a neurotransmitter in the sympathetic peripheral nervous system and in some tracts in the central nervous system. It is also the demethylated biosynthetic precursor of epinephrine.
2 P23772 (/IMP) P23772 (/IMP)
Pigment metabolic process GO:0042440
The chemical reactions and pathways involving pigment, any general or particular coloring matter in living organisms, e.g. melanin.
2 P52168 (/IMP) P52168 (/IMP)
Response to drug GO:0042493
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
2 P46153 (/IEP) Q99NH5 (/IEP)
Response to drug GO:0042493
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
2 Q08369 (/ISO) Q61169 (/ISO)
Chordate embryonic development GO:0043009
The process whose specific outcome is the progression of the embryo over time, from zygote formation through a stage including a notochord and neural tube until birth or egg hatching.
2 Q05AJ3 (/IMP) Q90410 (/IMP)
Otic placode formation GO:0043049
The initial developmental process that will lead to the formation of the vertebrate inner ear. The otic placode forms as a thickening of the head ectoderm adjacent to the developing hindbrain.
2 Q91428 (/IGI) Q91428 (/IGI)
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
2 P17679 (/ISO) Q61169 (/ISO)
Positive regulation of mast cell degranulation GO:0043306
Any process that activates or increases the frequency, rate or extent of mast cell degranulation.
2 O09100 (/ISO) O09100 (/ISO)
Regulation of CD4-positive, alpha-beta T cell differentiation GO:0043370
Any process that modulates the frequency, rate, or extent of CD4-positive, alpha-beta T cell differentiation.
2 P23772 (/IMP) P23772 (/IMP)
Regulation of neuron apoptotic process GO:0043523
Any process that modulates the occurrence or rate of cell death by apoptotic process in neurons.
2 P23772 (/IMP) P23772 (/IMP)
Ear development GO:0043583
The process whose specific outcome is the progression of the ear over time, from its formation to the mature structure. The ear is the sense organ in vertebrates that is specialized for the detection of sound, and the maintenance of balance. Includes the outer ear and middle ear, which collect and transmit sound waves; and the inner ear, which contains the organs of balance and (except in fish) hearing. Also includes the pinna, the visible part of the outer ear, present in some mammals.
2 P23772 (/ISO) P23772 (/ISO)
Response to estrogen GO:0043627
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by an estrogen, C18 steroid hormones that can stimulate the development of female sexual characteristics.
2 Q08369 (/IDA) Q61169 (/IDA)
Thymic T cell selection GO:0045061
The process of T cell selection that occurs in the thymus.
2 P23772 (/IMP) P23772 (/IMP)
T-helper 2 cell differentiation GO:0045064
The process in which a relatively unspecialized T cell acquires specialized features of a T-helper 2 (Th2) cell. A Th2 cell is a CD4-positive, alpha-beta T cell that has the phenotype GATA-3-positive and produces interleukin-4.
2 P23772 (/IDA) P23772 (/IDA)
Positive regulation of T cell differentiation GO:0045582
Any process that activates or increases the frequency, rate or extent of T cell differentiation.
2 P23772 (/IDA) P23772 (/IDA)
Positive regulation of cell differentiation GO:0045597
Any process that activates or increases the frequency, rate or extent of cell differentiation.
2 P23772 (/IMP) P23772 (/IMP)
Regulation of myeloid cell differentiation GO:0045637
Any process that modulates the frequency, rate or extent of myeloid cell differentiation.
2 Q05AJ3 (/IMP) Q90410 (/IMP)
Negative regulation of myeloid cell differentiation GO:0045638
Any process that stops, prevents, or reduces the frequency, rate or extent of myeloid cell differentiation.
2 O09100 (/IMP) O09100 (/IMP)
Positive regulation of erythrocyte differentiation GO:0045648
Any process that activates or increases the frequency, rate or extent of erythrocyte differentiation.
2 O09100 (/IDA) O09100 (/IDA)
Negative regulation of macrophage differentiation GO:0045650
Any process that stops, prevents, or reduces the frequency, rate or extent of macrophage differentiation.
2 O09100 (/IDA) O09100 (/IDA)
Positive regulation of megakaryocyte differentiation GO:0045654
Any process that activates or increases the frequency, rate or extent of megakaryocyte differentiation.
2 O09100 (/IDA) O09100 (/IDA)
Positive regulation of neuron differentiation GO:0045666
Any process that activates or increases the frequency, rate or extent of neuron differentiation.
2 Q924Y4 (/IMP) Q924Y4 (/IMP)
Positive regulation of neuron differentiation GO:0045666
Any process that activates or increases the frequency, rate or extent of neuron differentiation.
2 O09100 (/ISO) O09100 (/ISO)
Negative regulation of Notch signaling pathway GO:0045746
Any process that stops, prevents, or reduces the frequency, rate or extent of the Notch signaling pathway.
2 O09100 (/ISO) O09100 (/ISO)
Positive regulation of angiogenesis GO:0045766
Any process that activates or increases angiogenesis.
2 P43694 (/ISS) P43694 (/ISS)
Negative regulation of cell cycle GO:0045786
Any process that stops, prevents or reduces the rate or extent of progression through the cell cycle.
2 P23772 (/ISO) P23772 (/ISO)
Negative regulation of transcription, DNA-templated GO:0045892
Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.
2 P23771 (/IMP) P23825 (/IMP)
Negative regulation of transcription, DNA-templated GO:0045892
Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.
2 P52168 (/TAS) P52168 (/TAS)
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
2 P52168 (/NAS) P52168 (/NAS)
Sympathetic nervous system development GO:0048485
The process whose specific outcome is the progression of the sympathetic nervous system over time, from its formation to the mature structure. The sympathetic nervous system is one of the two divisions of the vertebrate autonomic nervous system (the other being the parasympathetic nervous system). The sympathetic preganglionic neurons have their cell bodies in the thoracic and lumbar regions of the spinal cord and connect to the paravertebral chain of sympathetic ganglia. Innervate heart and blood vessels, sweat glands, viscera and the adrenal medulla. Most sympathetic neurons, but not all, use noradrenaline as a post-ganglionic neurotransmitter.
2 P23772 (/IMP) P23772 (/IMP)
Lymph gland development GO:0048542
The process whose specific outcome is the progression of the lymph gland over time, from its formation to the mature structure. The lymph gland is one of the sites of hemocyte differentiation. It consists of three to six bilaterally paired lobes that are attached to the cardioblasts during larval stages, and it degenerates during pupal stages.
2 P52168 (/IMP) P52168 (/IMP)
Embryonic organ development GO:0048568
Development, taking place during the embryonic phase, of a tissue or tissues that work together to perform a specific function or functions. Development pertains to the process whose specific outcome is the progression of a structure over time, from its formation to the mature structure. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions.
2 P23772 (/IMP) P23772 (/IMP)
Developmental growth GO:0048589
The increase in size or mass of an entire organism, a part of an organism or a cell, where the increase in size or mass has the specific outcome of the progression of the organism over time from one condition to another.
2 P23772 (/IMP) P23772 (/IMP)
Embryonic foregut morphogenesis GO:0048617
The process in which the anatomical structures of the foregut are generated and organized, during the embryonic phase.
2 P43694 (/ISS) P43694 (/ISS)
Anatomical structure formation involved in morphogenesis GO:0048646
The developmental process pertaining to the initial formation of an anatomical structure from unspecified parts. This process begins with the specific processes that contribute to the appearance of the discrete structure and ends when the structural rudiment is recognizable. An anatomical structure is any biological entity that occupies space and is distinguished from its surroundings. Anatomical structures can be macroscopic such as a carpel, or microscopic such as an acrosome.
2 P23772 (/IMP) P23772 (/IMP)
Neuron fate commitment GO:0048663
The process in which the developmental fate of a cell becomes restricted such that it will develop into a neuron.
2 O09100 (/IMP) O09100 (/IMP)
Embryonic neurocranium morphogenesis GO:0048702
The process in which the anatomical structures of the neurocranium are generated and organized during the embryonic phase. The neurocranium is the portion of the vertebrate skull surrounding the brain.
2 Q91428 (/IGI) Q91428 (/IGI)
Embryonic neurocranium morphogenesis GO:0048702
The process in which the anatomical structures of the neurocranium are generated and organized during the embryonic phase. The neurocranium is the portion of the vertebrate skull surrounding the brain.
2 Q91428 (/IMP) Q91428 (/IMP)
Cardiac muscle tissue development GO:0048738
The process whose specific outcome is the progression of cardiac muscle over time, from its formation to the mature structure.
2 Q08369 (/IGI) Q61169 (/IGI)
Cardiac muscle tissue development GO:0048738
The process whose specific outcome is the progression of cardiac muscle over time, from its formation to the mature structure.
2 P70005 (/IMP) Q91677 (/IMP)
Homeostasis of number of cells GO:0048872
Any biological process involved in the maintenance of the steady-state number of cells within a population of cells.
2 P23772 (/IMP) P23772 (/IMP)
Homeostasis of number of cells within a tissue GO:0048873
Any biological process involved in the maintenance of the steady-state number of cells within a population of cells in a tissue.
2 O09100 (/IMP) O09100 (/IMP)
Negative regulation of inflammatory response GO:0050728
Any process that stops, prevents, or reduces the frequency, rate or extent of the inflammatory response.
2 P23772 (/ISO) P23772 (/ISO)
Positive regulation of peptidyl-tyrosine phosphorylation GO:0050731
Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine.
2 P15976 (/IMP) P17679 (/IMP)
Positive regulation of phagocytosis GO:0050766
Any process that activates or increases the frequency, rate or extent of phagocytosis.
2 Q924Y4 (/IDA) Q924Y4 (/IDA)
Positive regulation of phagocytosis GO:0050766
Any process that activates or increases the frequency, rate or extent of phagocytosis.
2 O09100 (/ISO) O09100 (/ISO)
Positive regulation of neurogenesis GO:0050769
Any process that activates or increases the frequency, rate or extent of neurogenesis, the generation of cells within the nervous system.
2 Q91428 (/IMP) Q91428 (/IMP)
T cell receptor signaling pathway GO:0050852
A series of molecular signals initiated by the cross-linking of an antigen receptor on a T cell.
2 P23772 (/IDA) P23772 (/IDA)
Regulation of histone H3-K4 methylation GO:0051569
Any process that modulates the frequency, rate or extent of the covalent addition of a methyl group to the lysine at position 4 of histone H3.
2 P23772 (/IDA) P23772 (/IDA)
Positive regulation of cardioblast differentiation GO:0051891
Any process that activates or increases the frequency, rate or extent of cardioblast differentiation, the process in which a relatively unspecialized mesodermal cell acquires the specialized structural and/or functional features of a cardioblast. A cardioblast is a cardiac precursor cell. It is a cell that has been committed to a cardiac fate, but will undergo more cell division rather than terminally differentiating.
2 Q08369 (/IEP) Q61169 (/IEP)
Positive regulation of cardioblast differentiation GO:0051891
Any process that activates or increases the frequency, rate or extent of cardioblast differentiation, the process in which a relatively unspecialized mesodermal cell acquires the specialized structural and/or functional features of a cardioblast. A cardioblast is a cardiac precursor cell. It is a cell that has been committed to a cardiac fate, but will undergo more cell division rather than terminally differentiating.
2 P43694 (/ISS) P43694 (/ISS)
Regulation of protein kinase B signaling GO:0051896
Any process that modulates the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
2 P43694 (/ISS) P43694 (/ISS)
Positive regulation of protein kinase B signaling GO:0051897
Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
2 P23772 (/ISO) P23772 (/ISO)
Parathyroid gland development GO:0060017
The process whose specific outcome is the progression of the parathyroid gland over time, from its formation to the mature structure. The parathyroid gland is an organ specialised for secretion of parathyroid hormone.
2 P23772 (/IMP) P23772 (/IMP)
Pharyngeal system development GO:0060037
The process whose specific outcome is the progression of the pharyngeal system over time, from its formation to the mature structure. The pharyngeal system is a transient embryonic complex that is specific to vertebrates. It comprises the pharyngeal arches, bulges of tissues of mesoderm and neural crest derivation through which pass nerves and pharyngeal arch arteries. The arches are separated internally by pharyngeal pouches, evaginations of foregut endoderm, and externally by pharyngeal clefts, invaginations of surface ectoderm. The development of the system ends when the stucture it contributes to are forming: the thymus, thyroid, parathyroids, maxilla, mandible, aortic arch, cardiac outflow tract, external and middle ear.
2 P23772 (/IMP) P23772 (/IMP)
Positive regulation of cardiac muscle cell proliferation GO:0060045
Any process that activates or increases the frequency, rate or extent of cardiac muscle cell proliferation.
2 Q08369 (/IGI) Q61169 (/IGI)
Heart contraction GO:0060047
The multicellular organismal process in which the heart decreases in volume in a characteristic way to propel blood through the body.
2 P52168 (/IMP) P52168 (/IMP)
Uterus development GO:0060065
The reproductive developmental process whose specific outcome is the progression of the uterus over time, from its formation to the mature structure.
2 P23772 (/IMP) P23772 (/IMP)
Positive regulation of phagocytosis, engulfment GO:0060100
Any process that activates or increases the frequency, rate or extent of the internalization of bacteria, immune complexes and other particulate matter or of an apoptotic cell by phagocytosis.
2 Q924Y4 (/IMP) Q924Y4 (/IMP)
Positive regulation of phagocytosis, engulfment GO:0060100
Any process that activates or increases the frequency, rate or extent of the internalization of bacteria, immune complexes and other particulate matter or of an apoptotic cell by phagocytosis.
2 O09100 (/ISO) O09100 (/ISO)
Primitive hemopoiesis GO:0060215
A first transient wave of blood cell production that, in vertebrates, gives rise to erythrocytes (red blood cells) and myeloid cells.
2 Q05AJ3 (/IMP) Q90410 (/IMP)
Hematopoietic stem cell differentiation GO:0060218
The process in which a relatively unspecialized cell acquires specialized features of a hematopoietic stem cell. A stem cell is a cell that retains the ability to divide and proliferate throughout life to provide progenitor cells that can differentiate into specialized cells.
2 F1QD30 (/IMP) Q6DG89 (/IMP)
Mesenchymal to epithelial transition GO:0060231
A transition where a mesenchymal cell establishes apical/basolateral polarity, forms intercellular adhesive junctions, synthesizes basement membrane components and becomes an epithelial cell.
2 P23772 (/ISO) P23772 (/ISO)
Mast cell differentiation GO:0060374
The process in which a relatively unspecialized myeloid precursor cell acquires the specialized features of a mast cell. A mast cell is a cell that is found in almost all tissues containing numerous basophilic granules and capable of releasing large amounts of histamine and heparin upon activation.
2 P23772 (/IDA) P23772 (/IDA)
Atrial septum morphogenesis GO:0060413
The developmental process in which atrial septum is generated and organized. The atrial septum separates the upper chambers (the atria) of the heart from one another.
2 P43694 (/IMP) P43694 (/IMP)
Ureteric bud formation GO:0060676
The developmental process pertaining to the initial formation of the ureteric bud from the Wolffian duct. This process begins when the bud protrudes from the duct and ends when it is a recognizable bud.
2 P23772 (/IMP) P23772 (/IMP)
Ectodermal placode formation GO:0060788
The developmental process in which an ectodermal placode forms. An ectodermal placode is a thickening of the ectoderm that is the primordium of many structures derived from the ectoderm.
2 Q91428 (/IGI) Q91428 (/IGI)
Semicircular canal development GO:0060872
The progression of the semicircular canal from its initial formation to the mature structure.
2 O09100 (/IMP) O09100 (/IMP)
Cardiac muscle tissue regeneration GO:0061026
The regrowth of cardiac muscle tissue to repair injured or damaged muscle fibers in the postnatal stage.
2 P43694 (/ISS) P43694 (/ISS)
Regulation of histone H3-K27 methylation GO:0061085
Any process that modulates the rate, frequency, or extent of histone H3-K27 methylation. Histone H3-K27 methylation is the modification of histone H3 by addition of a methyl group to lysine at position 27 of the histone.
2 P23772 (/IDA) P23772 (/IDA)
Canonical Wnt signaling pathway involved in metanephric kidney development GO:0061290
The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes that contribute to the progression of the metanephric kidney over time. In this pathway, the activated receptor signals via downstream effectors that result in the inhibition of beta-catenin phosphorylation, thereby preventing degradation of beta-catenin. Stabilized beta-catenin can then accumulate and travel to the nucleus to trigger changes in transcription of target genes.
2 P23772 (/IMP) P23772 (/IMP)
Pericardial nephrocyte differentiation GO:0061320
The process in which a relatively unspecialized cell acquires the specialized structural and/or functional features of a pericardial nephrocyte. A pericardial nephrocyte is an insect renal cell that filters hemolymph and is found with other pericardial nephrocytes in two rows flanking the dorsal vessel. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state.
2 P52168 (/IMP) P52168 (/IMP)
Negative regulation of fat cell proliferation GO:0070345
Any process that stops or decreases the rate or extent of fat cell proliferation.
2 O09100 (/ISO) O09100 (/ISO)
Positive regulation of ERK1 and ERK2 cascade GO:0070374
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
2 P43694 (/ISS) P43694 (/ISS)
Platelet aggregation GO:0070527
The adhesion of one platelet to one or more other platelets via adhesion molecules.
2 P15976 (/IMP) P17679 (/IMP)
Cellular response to cytokine stimulus GO:0071345
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cytokine stimulus.
2 P23772 (/IDA) P23772 (/IDA)
Cellular response to interleukin-4 GO:0071353
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-4 stimulus.
2 P23772 (/IDA) P23772 (/IDA)
Cellular response to gonadotropin stimulus GO:0071371
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a gonadotropin stimulus.
2 Q08369 (/IDA) Q61169 (/IDA)
Positive regulation of histone H3-K14 acetylation GO:0071442
Any process that activates or increases the frequency, rate or extent of the addition of an acetyl group to histone H3 at position 14 of the histone.
2 P23772 (/IDA) P23772 (/IDA)
Positive regulation of histone H3-K14 acetylation GO:0071442
Any process that activates or increases the frequency, rate or extent of the addition of an acetyl group to histone H3 at position 14 of the histone.
2 P23772 (/IMP) P23772 (/IMP)
Otic vesicle development GO:0071599
The process whose specific outcome is the progression of the otic vesicle over time, from its formation to the mature structure. The otic vesicle is a transient embryonic structure formed during development of the vertebrate inner ear.
2 P23772 (/IMP) P23772 (/IMP)
Ectodermal placode development GO:0071696
The progression of an ectodermal placode over time from its initial formation until its mature state. An ectodermal placode is a thickening of the ectoderm that is the primordium of many structures derived from the ectoderm.
2 Q91428 (/IMP) Q91428 (/IMP)
Positive regulation of ureteric bud formation GO:0072107
Any process that increases the rate or extent of the developmental process pertaining to the initial formation of the ureteric bud from the Wolffian duct.
2 P23772 (/IMP) P23772 (/IMP)
Nephric duct morphogenesis GO:0072178
The process in which the anatomical structures of the nephric duct are generated and organized. A nephric duct is a tube that drains a primitive kidney.
2 P23772 (/IMP) P23772 (/IMP)
Nephric duct formation GO:0072179
The developmental process pertaining to the initial formation of a nephric duct. A nephric duct is a tube that drains a primitive kidney.
2 P23772 (/IMP) P23772 (/IMP)
Regulation of nephron tubule epithelial cell differentiation GO:0072182
Any process that modulates the frequency, rate or extent of nephron tubule epithelial cell differentiation.
2 P23772 (/IMP) P23772 (/IMP)
Ureter morphogenesis GO:0072197
The process in which the anatomical structures of the ureter are generated and organized. The ureter is a muscular tube that transports urine from the kidney to the urinary bladder.
2 P23772 (/IGI) P23772 (/IGI)
Interleukin-4 secretion GO:0072602
The regulated release of interleukin-4 from a cell.
2 P23772 (/IMP) P23772 (/IMP)
Interferon-gamma secretion GO:0072643
The regulated release of interferon-gamma from a cell.
2 P23772 (/IMP) P23772 (/IMP)
Lymphocyte migration GO:0072676
The movement of a lymphocyte within or between different tissues and organs of the body.
2 P23772 (/ISO) P23772 (/ISO)
Positive regulation of cell migration involved in sprouting angiogenesis GO:0090050
Any process that increases the frequency, rate or extent of cell migration involved in sprouting angiogenesis. Cell migration involved in sprouting angiogenesis is the orderly movement of endothelial cells into the extracellular matrix in order to form new blood vessels contributing to the process of sprouting angiogenesis.
2 O09100 (/ISO) O09100 (/ISO)
GABAergic neuron differentiation GO:0097154
The process in which a neuroblast acquires the specialized structural and functional features of a GABAergic neuron.
2 O09100 (/IMP) O09100 (/IMP)
Negative regulation of DNA demethylation GO:1901536
Any process that stops, prevents or reduces the frequency, rate or extent of DNA demethylation.
2 P23772 (/IDA) P23772 (/IDA)
Negative regulation of DNA demethylation GO:1901536
Any process that stops, prevents or reduces the frequency, rate or extent of DNA demethylation.
2 P23772 (/IMP) P23772 (/IMP)
Positive regulation of pri-miRNA transcription by RNA polymerase II GO:1902895
Any process that activates or increases the frequency, rate or extent of pri-miRNA transcription mediated by RNA polymerase II.
2 O09100 (/ISO) O09100 (/ISO)
Negative regulation of oxidative stress-induced cell death GO:1903202
Any process that stops, prevents or reduces the frequency, rate or extent of oxidative stress-induced cell death.
2 P43694 (/ISS) P43694 (/ISS)
Positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis GO:1903589
Any process that activates or increases the frequency, rate or extent of blood vessel endothelial cell proliferation involved in sprouting angiogenesis.
2 O09100 (/ISO) O09100 (/ISO)
Regulation of establishment of cell polarity GO:2000114
Any process that modulates the frequency, rate or extent of establishment of cell polarity.
2 P23772 (/IDA) P23772 (/IDA)
Negative regulation of cell motility GO:2000146
Any process that stops, prevents, or reduces the frequency, rate or extent of cell motility.
2 P23772 (/ISO) P23772 (/ISO)
Negative regulation of neural precursor cell proliferation GO:2000178
Any process that stops, prevents, or reduces the frequency, rate or extent of neural precursor cell proliferation.
2 O09100 (/IMP) O09100 (/IMP)
Negative regulation of neural precursor cell proliferation GO:2000178
Any process that stops, prevents, or reduces the frequency, rate or extent of neural precursor cell proliferation.
2 O09100 (/ISO) O09100 (/ISO)
Positive regulation of T-helper 2 cell cytokine production GO:2000553
Any process that activates or increases the frequency, rate or extent of T-helper 2 cell cytokine production.
2 P23772 (/IMP) P23772 (/IMP)
Negative regulation of cell proliferation involved in mesonephros development GO:2000607
Any process that stops, prevents or reduces the frequency, rate or extent of cell proliferation involved in mesonephros development.
2 P23772 (/IMP) P23772 (/IMP)
Positive regulation of thyroid hormone generation GO:2000611
Any process that activates or increases the frequency, rate or extent of thyroid hormone generation.
2 P23772 (/ISO) P23772 (/ISO)
Positive regulation of histone H3-K9 acetylation GO:2000617
Any process that activates or increases the frequency, rate or extent of histone H3-K9 acetylation.
2 P23772 (/IDA) P23772 (/IDA)
Positive regulation of histone H3-K9 acetylation GO:2000617
Any process that activates or increases the frequency, rate or extent of histone H3-K9 acetylation.
2 P23772 (/IMP) P23772 (/IMP)
Positive regulation of interleukin-5 secretion GO:2000664
Any process that activates or increases the frequency, rate or extent of interleukin-5 secretion.
2 P23772 (/ISO) P23772 (/ISO)
Positive regulation of interleukin-13 secretion GO:2000667
Any process that activates or increases the frequency, rate or extent of interleukin-13 secretion.
2 P23772 (/ISO) P23772 (/ISO)
Positive regulation of transcription regulatory region DNA binding GO:2000679
Any process that activates or increases the frequency, rate or extent of transcription regulatory region DNA binding.
2 P23772 (/ISO) P23772 (/ISO)
Regulation of cellular response to X-ray GO:2000683
Any process that modulates the frequency, rate or extent of cellular response to X-ray.
2 P23772 (/ISO) P23772 (/ISO)
Negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation GO:2000703
Any process that stops, prevents or reduces the frequency, rate or extent of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation.
2 P23772 (/IMP) P23772 (/IMP)
Negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation GO:2000734
Any process that stops, prevents or reduces the frequency, rate or extent of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation.
2 P23772 (/IMP) P23772 (/IMP)
Regulation of forebrain neuron differentiation GO:2000977
Any process that modulates the frequency, rate or extent of forebrain neuron differentiation.
2 O09100 (/IMP) O09100 (/IMP)
Positive regulation of neuron migration GO:2001224
Any process that activates or increases the frequency, rate or extent of neuron migration.
2 Q91428 (/IMP) Q91428 (/IMP)
Negative regulation of apoptotic signaling pathway GO:2001234
Any process that stops, prevents or reduces the frequency, rate or extent of apoptotic signaling pathway.
2 P43694 (/ISS) P43694 (/ISS)
Negative regulation of transcription by RNA polymerase II GO:0000122
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
1 P17679 (/IGI)
Negative regulation of transcription by RNA polymerase II GO:0000122
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
1 P43429 (/ISS)
Gastrulation with mouth forming second GO:0001702
A gastrulation process in which the initial invagination becomes the anus and the mouth forms second.
1 Q08369 (/IMP)
Type IV hypersensitivity GO:0001806
An inflammatory response driven by T cell recognition of processed soluble or cell-associated antigens leading to cytokine release and leukocyte activation.
1 Q99NH5 (/IEP)
Kidney development GO:0001822
The process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and/or excretes the end products of body metabolism in the form of urine.
1 P23771 (/IMP)
Positive regulation of protein phosphorylation GO:0001934
Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein.
1 Q08369 (/IDA)
Heart looping GO:0001947
The tube morphogenesis process in which the primitive heart tube loops asymmetrically. This looping brings the primitive heart chambers into alignment preceding their future integration. Heart looping begins with dextral-looping and ends when the main regional divisions of the mature heart and primordium of the great arterial trunks become established preceeding septation.
1 Q08369 (/IMP)
Outflow tract septum morphogenesis GO:0003148
The process in which the anatomical structures of the outflow tract septum are generated and organized. The outflow tract septum is a partition in the outflow tract.
1 Q92908 (/IMP)
Outflow tract septum morphogenesis GO:0003148
The process in which the anatomical structures of the outflow tract septum are generated and organized. The outflow tract septum is a partition in the outflow tract.
1 Q61169 (/ISO)
Outflow tract morphogenesis GO:0003151
The process in which the anatomical structures of the outflow tract are generated and organized. The outflow tract is the portion of the heart through which blood flows into the arteries.
1 Q08369 (/TAS)
Atrioventricular valve morphogenesis GO:0003181
The process in which the structure of the atrioventricular valve is generated and organized.
1 Q08369 (/IGI)
Atrioventricular valve morphogenesis GO:0003181
The process in which the structure of the atrioventricular valve is generated and organized.
1 Q08369 (/TAS)
Atrioventricular valve formation GO:0003190
The developmental process pertaining to the initial formation of the atrioventricular valve from unspecified parts. This process begins with the specific processes that contribute to the appearance of the discrete structure and ends when the structural rudiment is recognizable.
1 Q08369 (/IGI)
Mitral valve formation GO:0003192
The developmental process pertaining to the initial formation of the mitral valve from unspecified parts. This process begins with the specific processes that contribute to the appearance of the discrete structure and ends when the structural rudiment is recognizable.
1 Q08369 (/TAS)
Tricuspid valve formation GO:0003195
The developmental process pertaining to the initial formation of the tricuspid valve from unspecified parts. This process begins with the specific processes that contribute to the appearance of the discrete structure and ends when the structural rudiment is recognizable.
1 Q08369 (/TAS)
Endocardial cushion development GO:0003197
The progression of a cardiac cushion over time, from its initial formation to the mature structure. The endocardial cushion is a specialized region of mesenchymal cells that will give rise to the heart septa and valves.
1 Q08369 (/IGI)
Endocardial cushion development GO:0003197
The progression of a cardiac cushion over time, from its initial formation to the mature structure. The endocardial cushion is a specialized region of mesenchymal cells that will give rise to the heart septa and valves.
1 Q08369 (/ISO)
Ventricular cardiac muscle tissue development GO:0003229
The process whose specific outcome is the progression of ventricular cardiac muscle over time, from its formation to the mature structure.
1 Q08369 (/IGI)
Endocardial cushion fusion GO:0003274
The cell-cell adhesion process of mesenchymal cardiac cushion cells that contributes to the process of cushion shaping.
1 P97489 (/IMP)
Endocardial cushion fusion GO:0003274
The cell-cell adhesion process of mesenchymal cardiac cushion cells that contributes to the process of cushion shaping.
1 Q9BWX5 (/ISS)
Cardiac septum development GO:0003279
The progression of a cardiac septum over time, from its initial formation to the mature structure.
1 Q08369 (/IGI)
Atrial septum primum morphogenesis GO:0003289
The process in which anatomical structure of an atrial septum primum is generated and organized.
1 Q08369 (/IMP)
Atrial septum secundum morphogenesis GO:0003290
The process in which anatomical structure of an atrial septum secundum is generated and organized.
1 Q08369 (/ISO)
Type B pancreatic cell differentiation GO:0003309
The process in which relatively unspecialized cells acquire specialized structural and/or functional features of a type B pancreatic cell. A type B pancreatic cell is a cell located towards center of the islets of Langerhans that secretes insulin.
1 Q61169 (/IMP)
Pancreatic A cell differentiation GO:0003310
The process in which relatively unspecialized cells acquire specialized structural and functional features of a pancreatic A cell. A pancreatic A cell is a cell in the pancreas that secretes glucagon.
1 Q61169 (/IMP)
Transcription, DNA-templated GO:0006351
The cellular synthesis of RNA on a template of DNA.
1 Q16365 (/NAS)
Regulation of transcription, DNA-templated GO:0006355
Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription.
1 Q08369 (/ISO)
Transcription by RNA polymerase II GO:0006366
The synthesis of RNA from a DNA template by RNA polymerase II (RNAP II), originating at an RNA polymerase II promoter. Includes transcription of messenger RNA (mRNA) and certain small nuclear RNAs (snRNAs).
1 P23771 (/TAS)
Phospholipid metabolic process GO:0006644
The chemical reactions and pathways involving phospholipids, any lipid containing phosphoric acid as a mono- or diester.
1 Q61169 (/IGI)
Defense response GO:0006952
Reactions, triggered in response to the presence of a foreign body or the occurrence of an injury, which result in restriction of damage to the organism attacked or prevention/recovery from the infection caused by the attack.
1 P23771 (/TAS)
Spermatogenesis GO:0007283
The process of formation of spermatozoa, including spermatocytogenesis and spermiogenesis.
1 Q08369 (/IMP)
Axon guidance GO:0007411
The chemotaxis process that directs the migration of an axon growth cone to a specific target site in response to a combination of attractive and repulsive cues.
1 P23825 (/NAS)
Endodermal cell fate determination GO:0007493
The cell fate determination process in which a cell becomes capable of differentiating autonomously into an endoderm cell regardless of its environment; upon determination, the cell fate cannot be reversed.
1 Q61169 (/IDA)
Motor neuron axon guidance GO:0008045
The process in which the migration of an axon growth cone of a motor neuron is directed to a specific target site in response to a combination of attractive and repulsive cues.
1 P91623 (/IMP)
Response to mechanical stimulus GO:0009612
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus.
1 P46152 (/IDA)
Response to mechanical stimulus GO:0009612
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus.
1 Q08369 (/ISO)
Response to virus GO:0009615
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a virus.
1 P23771 (/IEP)
Response to toxic substance GO:0009636
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a toxic stimulus.
1 P46153 (/IEP)
Anatomical structure morphogenesis GO:0009653
The process in which anatomical structures are generated and organized. Morphogenesis pertains to the creation of form.
1 P23771 (/TAS)
Animal organ morphogenesis GO:0009887
Morphogenesis of an animal organ. An organ is defined as a tissue or set of tissues that work together to perform a specific function or functions. Morphogenesis is the process in which anatomical structures are generated and organized. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions.
1 P91623 (/IMP)
Tissue development GO:0009888
The process whose specific outcome is the progression of a tissue over time, from its formation to the mature structure.
1 P91623 (/IMP)
Positive regulation of signal transduction GO:0009967
Any process that activates or increases the frequency, rate or extent of signal transduction.
1 P23771 (/IMP)
Response to gamma radiation GO:0010332
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a gamma radiation stimulus. Gamma radiation is a form of electromagnetic radiation (EMR) or light emission of a specific frequency produced from sub-atomic particle interaction, such as electron-positron annihilation and radioactive decay. Gamma rays are generally characterized as EMR having the highest frequency and energy, and also the shortest wavelength, within the electromagnetic radiation spectrum.
1 Q99NH5 (/IEP)
Negative regulation of autophagy GO:0010507
Any process that stops, prevents, or reduces the frequency, rate or extent of autophagy. Autophagy is the process in which cells digest parts of their own cytoplasm.
1 P46152 (/IMP)
Negative regulation of autophagy GO:0010507
Any process that stops, prevents, or reduces the frequency, rate or extent of autophagy. Autophagy is the process in which cells digest parts of their own cytoplasm.
1 Q08369 (/ISO)
Regulation of glycoprotein biosynthetic process GO:0010559
Any process that modulates the rate, frequency, or extent of the chemical reactions and pathways resulting in the formation of glycoproteins, any protein that contains covalently bound glycose (i.e. monosaccharide) residues; the glycose occurs most commonly as oligosaccharide or fairly small polysaccharide but occasionally as monosaccharide.
1 P17679 (/ISO)
Positive regulation of vascular endothelial growth factor production GO:0010575
Any process that increases or activates the frequency, rate, or extent of production of vascular endothelial growth factor.
1 Q08369 (/IDA)
Positive regulation of endothelial cell migration GO:0010595
Any process that increases the rate, frequency, or extent of the orderly movement of an endothelial cell into the extracellular matrix to form an endothelium.
1 P23771 (/IMP)
Negative regulation of cardiac muscle hypertrophy GO:0010614
Any process that decreases the rate, frequency or extent of the enlargement or overgrowth of all or part of the heart due to an increase in size (not length) of individual cardiac muscle fibers, without cell division.
1 P97489 (/IMP)
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
1 Q08369 (/IDA)
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
1 Q9BWX5 (/ISS)
Negative regulation of gene expression GO:0010629
Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
1 Q08369 (/IDA)
Negative regulation of gene expression GO:0010629
Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
1 Q9BWX5 (/ISS)
Positive regulation of cardiac muscle cell apoptotic process GO:0010666
Any process that increases the rate or extent of cardiac cell apoptotic process, a form of programmed cell death induced by external or internal signals that trigger the activity of proteolytic caspases whose actions dismantle a cardiac muscle cell and result in its death.
1 P46153 (/IMP)
Positive regulation of cardiac muscle cell apoptotic process GO:0010666
Any process that increases the rate or extent of cardiac cell apoptotic process, a form of programmed cell death induced by external or internal signals that trigger the activity of proteolytic caspases whose actions dismantle a cardiac muscle cell and result in its death.
1 Q61169 (/ISO)
Negative regulation of cardiac muscle cell apoptotic process GO:0010667
Any process that decreases the rate or extent of cardiac cell apoptotic process, a form of programmed cell death induced by external or internal signals that trigger the activity of proteolytic caspases whose actions dismantle a cardiac muscle cell and result in its death.
1 Q08369 (/IGI)
Regulation of definitive erythrocyte differentiation GO:0010724
Any process that modulates the rate, frequency, or extent of definitive erythrocyte differentiation. Definitive erythrocyte differentiation occurs as part of the process of definitive hemopoiesis.
1 P17679 (/ISO)
Protein deubiquitination GO:0016579
The removal of one or more ubiquitin groups from a protein.
1 P23771 (/TAS)
Cytokine-mediated signaling pathway GO:0019221
A series of molecular signals initiated by the binding of a cytokine to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
1 P23771 (/TAS)
Signal transduction involved in regulation of gene expression GO:0023019
Any process that modulates the frequency, rate or extent of gene expression as a consequence of a process in which a signal is released and/or conveyed from one location to another.
1 Q08369 (/IDA)
Myeloid cell differentiation GO:0030099
The process in which a relatively unspecialized myeloid precursor cell acquires the specialized features of any cell of the myeloid leukocyte, megakaryocyte, thrombocyte, or erythrocyte lineages.
1 P17679 (/IMP)
Erythrocyte differentiation GO:0030218
The process in which a myeloid precursor cell acquires specializes features of an erythrocyte.
1 P15976 (/IEP)
Megakaryocyte differentiation GO:0030219
The process in which a myeloid precursor cell acquires specializes features of a megakaryocyte.
1 P17679 (/IDA)
Megakaryocyte differentiation GO:0030219
The process in which a myeloid precursor cell acquires specializes features of a megakaryocyte.
1 P17679 (/IGI)
Megakaryocyte differentiation GO:0030219
The process in which a myeloid precursor cell acquires specializes features of a megakaryocyte.
1 P17679 (/ISO)
Platelet formation GO:0030220
The process in which platelets bud from long processes extended by megakaryocytes.
1 P17679 (/ISO)
Basophil differentiation GO:0030221
The process in which a relatively unspecialized myeloid precursor cell acquires specialized features of a basophil cell.
1 P15976 (/IEP)
Eosinophil differentiation GO:0030222
The process in which a relatively unspecialized myeloid precursor cell acquires the specializes features of an eosinophil.
1 P15976 (/IEP)
Negative regulation of bone mineralization GO:0030502
Any process that stops, prevents, or reduces the frequency, rate or extent of bone mineralization.
1 P17679 (/IMP)
BMP signaling pathway GO:0030509
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
1 Q08369 (/IDA)
Epithelial cell differentiation GO:0030855
The process in which a relatively unspecialized cell acquires specialized features of an epithelial cell, any of the cells making up an epithelium.
1 Q61169 (/IMP)
Animal organ regeneration GO:0031100
The regrowth of a lost or destroyed animal organ.
1 P43429 (/IDA)
Response to retinoic acid GO:0032526
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a retinoic acid stimulus.
1 Q08369 (/IDA)
Response to retinoic acid GO:0032526
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a retinoic acid stimulus.
1 P43691 (/TAS)
Negative regulation of transforming growth factor beta1 production GO:0032911
Any process that stops, prevents, or reduces the frequency, rate, or extent of production of transforming growth factor-beta1.
1 Q92908 (/IMP)
Negative regulation of transforming growth factor beta1 production GO:0032911
Any process that stops, prevents, or reduces the frequency, rate, or extent of production of transforming growth factor-beta1.
1 Q61169 (/ISO)
Negative regulation of transforming growth factor beta2 production GO:0032912
Any process that stops, prevents, or reduces the frequency, rate, or extent of production of transforming growth factor-beta2.
1 Q92908 (/IMP)
Negative regulation of transforming growth factor beta2 production GO:0032912
Any process that stops, prevents, or reduces the frequency, rate, or extent of production of transforming growth factor-beta2.
1 Q61169 (/ISO)
Response to vitamin A GO:0033189
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin A stimulus.
1 P46152 (/IEP)
Negative regulation of mammary gland epithelial cell proliferation GO:0033600
Any process that stops, prevents or reduces the rate or extent of mammary gland epithelial cell proliferation.
1 P23771 (/IDA)
Positive regulation of osteoblast proliferation GO:0033690
Any process that activates or increases the rate or extent of osteoblast proliferation.
1 P17679 (/IMP)
Embryonic heart tube anterior/posterior pattern specification GO:0035054
The establishment, maintenance and elaboration of cell differentiation that results in the anterior/posterior subdivision of the embryonic heart tube. In Drosophila this results in subdivision of the dorsal vessel into to the posterior heart proper and the anterior aorta.
1 Q08369 (/IMP)
Cellular response to interferon-alpha GO:0035457
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interferon-alpha stimulus. Interferon-alpha is a type I interferon.
1 P23771 (/IEP)
Positive regulation of Notch signaling pathway involved in heart induction GO:0035481
Any process that activates or increases the frequency, rate or extent of the series of molecular signals initiated by binding of an extracellular ligand to a Notch receptor on the surface of the target cell that contributes to heart induction.
1 P97489 (/IMP)
Positive regulation of Notch signaling pathway involved in heart induction GO:0035481
Any process that activates or increases the frequency, rate or extent of the series of molecular signals initiated by binding of an extracellular ligand to a Notch receptor on the surface of the target cell that contributes to heart induction.
1 Q9BWX5 (/ISS)
Skeletal muscle cell differentiation GO:0035914
The process in which a relatively unspecialized cell acquires specialized features of a skeletal muscle cell, a somatic cell located in skeletal muscle.
1 Q08369 (/NAS)
Endodermal cell differentiation GO:0035987
The process in which a relatively unspecialized cell acquires the specialized features of an endoderm cell, a cell of the inner of the three germ layers of the embryo.
1 Q61169 (/IMP)
Atrioventricular canal development GO:0036302
The progression of the atrioventricular canal over time, from its formation to the mature structure. The atrioventricular canal is the part of the heart connecting the atrium to the cardiac ventricle.
1 Q08369 (/IGI)
Odontogenesis of dentin-containing tooth GO:0042475
The process whose specific outcome is the progression of a dentin-containing tooth over time, from its formation to the mature structure. A dentin-containing tooth is a hard, bony organ borne on the jaw or other bone of a vertebrate, and is composed mainly of dentin, a dense calcified substance, covered by a layer of enamel.
1 P46153 (/IEP)
Inner ear auditory receptor cell differentiation GO:0042491
The process in which a relatively unspecialized inner cell acquires specialized features of an auditory hair cell.
1 P23825 (/IEP)
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
1 Q61169 (/ISO)
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
1 Q08369 (/IDA)
Ear development GO:0043583
The process whose specific outcome is the progression of the ear over time, from its formation to the mature structure. The ear is the sense organ in vertebrates that is specialized for the detection of sound, and the maintenance of balance. Includes the outer ear and middle ear, which collect and transmit sound waves; and the inner ear, which contains the organs of balance and (except in fish) hearing. Also includes the pinna, the visible part of the outer ear, present in some mammals.
1 P23771 (/IMP)
Response to estrogen GO:0043627
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by an estrogen, C18 steroid hormones that can stimulate the development of female sexual characteristics.
1 P23771 (/IEP)
Cellular protein metabolic process GO:0044267
The chemical reactions and pathways involving a specific protein, rather than of proteins in general, occurring at the level of an individual cell. Includes cellular protein modification.
1 Q92908 (/TAS)
Response to ethanol GO:0045471
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ethanol stimulus.
1 Q99NH5 (/IEP)
Positive regulation of erythrocyte differentiation GO:0045648
Any process that activates or increases the frequency, rate or extent of erythrocyte differentiation.
1 P15976 (/IMP)
Positive regulation of erythrocyte differentiation GO:0045648
Any process that activates or increases the frequency, rate or extent of erythrocyte differentiation.
1 P17679 (/ISO)
Regulation of megakaryocyte differentiation GO:0045652
Any process that modulates the frequency, rate or extent of megakaryocyte differentiation.
1 P15976 (/TAS)
Positive regulation of cell cycle GO:0045787
Any process that activates or increases the rate or extent of progression through the cell cycle.
1 Q08369 (/IDA)
Negative regulation of transcription, DNA-templated GO:0045892
Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.
1 Q92908 (/IDA)
Cell development GO:0048468
The process whose specific outcome is the progression of the cell over time, from its formation to the mature structure. Cell development does not include the steps involved in committing a cell to a specific fate.
1 P17679 (/IMP)
Embryonic digestive tract morphogenesis GO:0048557
The process in which the anatomical structures of the digestive tract are generated and organized during embryonic development. The digestive tract is the anatomical structure through which food passes and is processed.
1 Q08369 (/IMP)
Embryonic morphogenesis GO:0048598
The process in which anatomical structures are generated and organized during the embryonic phase. The embryonic phase begins with zygote formation. The end of the embryonic phase is organism-specific. For example, it would be at birth for mammals, larval hatching for insects and seed dormancy in plants.
1 Q08369 (/IMP)
Embryonic foregut morphogenesis GO:0048617
The process in which the anatomical structures of the foregut are generated and organized, during the embryonic phase.
1 Q08369 (/IMP)
Animal organ formation GO:0048645
The process pertaining to the initial formation of an animal organ from unspecified parts. The process begins with the specific processes that contribute to the appearance of the discrete structure, such as inductive events, and ends when the structural rudiment of the organ is recognizable, such as a condensation of mesenchymal cells into the organ rudiment. Organs are a natural part or structure in an animal or a plant, capable of performing some special action (termed its function), which is essential to the life or well-being of the whole. The heart and lungs are organs of animals, and the petal and leaf are organs of plants. In animals the organs are generally made up of several tissues, one of which usually predominates, and determines the principal function of the organ.
1 Q61169 (/IMP)
Erythrocyte development GO:0048821
The process whose specific outcome is the progression of an erythrocyte over time, from its formation to the mature structure.
1 P17679 (/ISO)
Negative regulation of inflammatory response GO:0050728
Any process that stops, prevents, or reduces the frequency, rate or extent of the inflammatory response.
1 P23771 (/IMP)
Positive regulation of peptidyl-tyrosine phosphorylation GO:0050731
Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine.
1 P17679 (/ISO)
Smooth muscle cell differentiation GO:0051145
The process in which a relatively unspecialized cell acquires specialized features of a smooth muscle cell; smooth muscle lacks transverse striations in its constituent fibers and are almost always involuntary.
1 Q92908 (/IMP)
Smooth muscle cell differentiation GO:0051145
The process in which a relatively unspecialized cell acquires specialized features of a smooth muscle cell; smooth muscle lacks transverse striations in its constituent fibers and are almost always involuntary.
1 Q61169 (/ISO)
Response to cAMP GO:0051591
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate) stimulus.
1 P46153 (/IEP)
Regulation of protein kinase B signaling GO:0051896
Any process that modulates the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
1 Q08369 (/IDA)
Positive regulation of protein kinase B signaling GO:0051897
Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
1 P23771 (/IMP)
Cardiac muscle cell differentiation GO:0055007
The process in which a cardiac muscle precursor cell acquires specialized features of a cardiac muscle cell. Cardiac muscle cells are striated muscle cells that are responsible for heart contraction.
1 Q08369 (/NAS)
Sertoli cell differentiation GO:0060008
The process in which a relatively unspecialized cell acquires specialized structural and/or functional features of a Sertoli cell. A Sertoli cell is a supporting cell projecting inward from the basement membrane of seminiferous tubules.
1 Q08369 (/IMP)
Sertoli cell development GO:0060009
The process whose specific outcome is the progression of a Sertoli cell over time, from its formation to the mature structure. Cell development does not include the steps involved in committing a cell to a Sertoli cell fate.
1 P43429 (/IEP)
Regulation of cardiac muscle cell proliferation GO:0060043
Any process that modulates the frequency, rate or extent of cardiac muscle cell proliferation.
1 Q08369 (/IMP)
Canonical Wnt signaling pathway GO:0060070
The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes. In this pathway, the activated receptor signals via downstream effectors that result in the inhibition of beta-catenin phosphorylation, thereby preventing degradation of beta-catenin. Stabilized beta-catenin can then accumulate and travel to the nucleus to trigger changes in transcription of target genes.
1 Q08369 (/IDA)
Mesenchymal to epithelial transition GO:0060231
A transition where a mesenchymal cell establishes apical/basolateral polarity, forms intercellular adhesive junctions, synthesizes basement membrane components and becomes an epithelial cell.
1 P23771 (/IDA)
Transdifferentiation GO:0060290
The conversion of a differentiated cell of one fate into a differentiated cell of another fate without first undergoing cell division or reversion to a more primitive or stem cell-like fate.
1 P46152 (/IMP)
Transdifferentiation GO:0060290
The conversion of a differentiated cell of one fate into a differentiated cell of another fate without first undergoing cell division or reversion to a more primitive or stem cell-like fate.
1 Q08369 (/ISO)
SMAD protein signal transduction GO:0060395
The cascade of processes by which a signal interacts with a receptor, causing a change in the activity of a SMAD protein, and ultimately effecting a change in the functioning of the cell.
1 Q08369 (/IDA)
Atrial septum morphogenesis GO:0060413
The developmental process in which atrial septum is generated and organized. The atrial septum separates the upper chambers (the atria) of the heart from one another.
1 Q08369 (/ISO)
Lung morphogenesis GO:0060425
The process in which the anatomical structures of the lung are generated and organized.
1 Q08369 (/TAS)
Lung saccule development GO:0060430
The biological process whose specific outcome is the progression of a lung saccule from an initial condition to its mature state. The lung saccule is the primitive gas exchange portion of the lung composed of type I and type II cells.
1 Q61169 (/IGI)
Lung lobe formation GO:0060464
The developmental process pertaining to the initial formation of a lung lobe from unspecified parts. This process begins with the specific processes that contribute to the appearance of the lobe and ends when the structural rudiment is recognizable. A lung lobe is a projection that extends from the lung.
1 Q08369 (/IMP)
Clara cell differentiation GO:0060486
The process in which a relatively unspecialized cell acquires specialized features of a Clara cell. A Clara cell is an unciliated epithelial cell found in the respiratory and terminal bronchioles.
1 Q61169 (/IGI)
Type II pneumocyte differentiation GO:0060510
The process in which a relatively unspecialized cell acquires specialized features of a type II pneumocyte. A type II pneumocyte is a surfactant secreting cell that contains abundant cytoplasm containing numerous lipid-rich multilamellar bodies.
1 Q61169 (/IGI)
Diaphragm morphogenesis GO:0060540
The process in which the anatomical structures of the diaphragm are generated and organized.
1 Q08369 (/TAS)
Cardiac vascular smooth muscle cell differentiation GO:0060947
The process in which a relatively unspecialized cell acquires specialized features of a cardiac vascular smooth muscle cell. A cardiac vascular smooth muscle cell covers the heart vasculature and lacks transverse striations in its constituent fibers.
1 Q92908 (/IMP)
Cardiac vascular smooth muscle cell differentiation GO:0060947
The process in which a relatively unspecialized cell acquires specialized features of a cardiac vascular smooth muscle cell. A cardiac vascular smooth muscle cell covers the heart vasculature and lacks transverse striations in its constituent fibers.
1 Q61169 (/ISO)
Vasculogenesis involved in coronary vascular morphogenesis GO:0060979
The differentiation of endothelial cells from progenitor cells that contributes to blood vessel development in the heart, and the de novo formation of blood vessels and tubes.
1 Q08369 (/TAS)
Cardiac muscle tissue regeneration GO:0061026
The regrowth of cardiac muscle tissue to repair injured or damaged muscle fibers in the postnatal stage.
1 Q08369 (/IDA)
Cell growth involved in cardiac muscle cell development GO:0061049
The growth of a cardiac muscle cell, where growth contributes to the progression of the cell over time from its initial formation to its mature state.
1 P46152 (/IDA)
Cell growth involved in cardiac muscle cell development GO:0061049
The growth of a cardiac muscle cell, where growth contributes to the progression of the cell over time from its initial formation to its mature state.
1 Q08369 (/ISO)
Positive regulation of cardiac endothelial to mesenchymal transition GO:0062000
Any process that activates or increases the frequency, rate or extent of cardiac endothelial to mesenchymal trnasition.
1 P97489 (/IMP)
Positive regulation of cardiac endothelial to mesenchymal transition GO:0062000
Any process that activates or increases the frequency, rate or extent of cardiac endothelial to mesenchymal trnasition.
1 Q9BWX5 (/ISS)
Positive regulation of ERK1 and ERK2 cascade GO:0070374
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
1 Q08369 (/IDA)
Platelet aggregation GO:0070527
The adhesion of one platelet to one or more other platelets via adhesion molecules.
1 P17679 (/ISO)
Response to growth factor GO:0070848
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a growth factor stimulus.
1 Q92908 (/IDA)
Response to growth factor GO:0070848
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a growth factor stimulus.
1 Q61169 (/ISO)
Positive regulation of cell cycle arrest GO:0071158
Any process that increases the rate, frequency, or extent of cell cycle arrest, the process in which the cell cycle is halted during one of the normal phases.
1 Q92908 (/IDA)
Positive regulation of cell cycle arrest GO:0071158
Any process that increases the rate, frequency, or extent of cell cycle arrest, the process in which the cell cycle is halted during one of the normal phases.
1 Q61169 (/ISO)
Cellular response to lipopolysaccharide GO:0071222
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
1 P43429 (/IDA)
Cellular response to cAMP GO:0071320
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate) stimulus.
1 P43429 (/IEP)
Cellular response to glucose stimulus GO:0071333
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucose stimulus.
1 P46152 (/IEP)
Cellular response to tumor necrosis factor GO:0071356
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a tumor necrosis factor stimulus.
1 P23771 (/IEP)
Cellular response to follicle-stimulating hormone stimulus GO:0071372
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a follicle-stimulating hormone stimulus.
1 Q08369 (/IDA)
Cellular response to follicle-stimulating hormone stimulus GO:0071372
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a follicle-stimulating hormone stimulus.
1 P43429 (/IEP)
Cellular response to hypoxia GO:0071456
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
1 Q92908 (/IDA)
Cellular response to hypoxia GO:0071456
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
1 Q61169 (/ISO)
Transcriptional activation by promoter-enhancer looping GO:0071733
The formation and maintenance of DNA loops that juxtapose the promoter and enhancer regions of RNA polymerase II-transcribed genes and activate transcription from an RNA polymerase II promoter.
1 P17679 (/IDA)
Transcriptional activation by promoter-enhancer looping GO:0071733
The formation and maintenance of DNA loops that juxtapose the promoter and enhancer regions of RNA polymerase II-transcribed genes and activate transcription from an RNA polymerase II promoter.
1 P15976 (/ISS)
Epithelial cell fate commitment GO:0072148
The process in which the developmental fate of a cell becomes restricted such that it will develop into an epithelial cell.
1 Q08369 (/IMP)
Seminiferous tubule development GO:0072520
The reproductive developmental process whose specific outcome is the progression of the seminiferous tubule over time, from its formation to the mature structure. Seminiferous tubules are ducts located in the testicles, and are the specific location of meiosis, and the subsequent creation of gametes, namely spermatozoa.
1 Q08369 (/IMP)
Lymphocyte migration GO:0072676
The movement of a lymphocyte within or between different tissues and organs of the body.
1 P23771 (/IDA)
Regulation of cardiac muscle cell contraction GO:0086004
Any process that modulates the frequency, rate or extent of cardiac muscle cell contraction.
1 P46152 (/IMP)
Regulation of cardiac muscle cell contraction GO:0086004
Any process that modulates the frequency, rate or extent of cardiac muscle cell contraction.
1 Q08369 (/ISO)
Dendritic cell differentiation GO:0097028
The process in which a precursor cell type acquires the specialized features of a dendritic cell. A dendritic cell is a leukocyte of dendritic lineage specialized in the uptake, processing, and transport of antigens to lymph nodes for the purpose of stimulating an immune response via T cell activation.
1 P17679 (/IDA)
Cellular response to thyroid hormone stimulus GO:0097067
A change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a thyroid hormone stimulus.
1 P15976 (/IDA)
Cellular response to thyroid hormone stimulus GO:0097067
A change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a thyroid hormone stimulus.
1 P17679 (/ISO)
Positive regulation of cardiac muscle myoblast proliferation GO:0110024
Any process that activates or increases the frequency, rate or extent of cardiac muscle myoblast proliferation.
1 Q92908 (/IDA)
Positive regulation of cardiac muscle myoblast proliferation GO:0110024
Any process that activates or increases the frequency, rate or extent of cardiac muscle myoblast proliferation.
1 Q61169 (/ISO)
Positive regulation of transcription from RNA polymerase II promoter involved in heart development GO:1901228
Any positive regulation of transcription from RNA polymerase II promoter that is involved in heart development.
1 P97489 (/IDA)
Positive regulation of transcription from RNA polymerase II promoter involved in heart development GO:1901228
Any positive regulation of transcription from RNA polymerase II promoter that is involved in heart development.
1 Q9BWX5 (/ISS)
Negative regulation of pri-miRNA transcription by RNA polymerase II GO:1902894
Any process that stops, prevents or reduces the frequency, rate or extent of pri-miRNA transcription mediated by RNA polymerase II.
1 P46153 (/IMP)
Negative regulation of pri-miRNA transcription by RNA polymerase II GO:1902894
Any process that stops, prevents or reduces the frequency, rate or extent of pri-miRNA transcription mediated by RNA polymerase II.
1 Q61169 (/ISO)
Negative regulation of oxidative stress-induced cell death GO:1903202
Any process that stops, prevents or reduces the frequency, rate or extent of oxidative stress-induced cell death.
1 Q08369 (/IDA)
Negative regulation of connective tissue replacement GO:1905204
Any process that stops, prevents or reduces the frequency, rate or extent of connective tissue replacement.
1 Q08369 (/IDA)
Negative regulation of cell motility GO:2000146
Any process that stops, prevents, or reduces the frequency, rate or extent of cell motility.
1 P23771 (/IMP)
Positive regulation of thyroid hormone generation GO:2000611
Any process that activates or increases the frequency, rate or extent of thyroid hormone generation.
1 P23771 (/IMP)
Positive regulation of interleukin-5 secretion GO:2000664
Any process that activates or increases the frequency, rate or extent of interleukin-5 secretion.
1 P23771 (/IDA)
Positive regulation of interleukin-13 secretion GO:2000667
Any process that activates or increases the frequency, rate or extent of interleukin-13 secretion.
1 P23771 (/IDA)
Positive regulation of interleukin-13 secretion GO:2000667
Any process that activates or increases the frequency, rate or extent of interleukin-13 secretion.
1 P23771 (/IMP)
Negative regulation of transcription regulatory region DNA binding GO:2000678
Any process that stops, prevents or reduces the frequency, rate or extent of transcription regulatory region DNA binding.
1 P15976 (/IDA)
Negative regulation of transcription regulatory region DNA binding GO:2000678
Any process that stops, prevents or reduces the frequency, rate or extent of transcription regulatory region DNA binding.
1 P17679 (/ISO)
Regulation of cellular response to X-ray GO:2000683
Any process that modulates the frequency, rate or extent of cellular response to X-ray.
1 P23771 (/IMP)
Negative regulation of apoptotic signaling pathway GO:2001234
Any process that stops, prevents or reduces the frequency, rate or extent of apoptotic signaling pathway.
1 Q08369 (/IDA)
Negative regulation of extrinsic apoptotic signaling pathway in absence of ligand GO:2001240
Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway in absence of ligand.
1 P15976 (/IMP)
Negative regulation of extrinsic apoptotic signaling pathway in absence of ligand GO:2001240
Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway in absence of ligand.
1 P17679 (/ISO)

There are 27 GO terms relating to "cellular component"

The search results have been sorted with the annotations that are found most frequently at the top of the list. The results can be filtered by typing text into the search box at the top of the table.
GO Term Annotations Evidence
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
36 E1C9C6 (/IDA) I3LUZ9 (/IDA) O09100 (/IDA) O09100 (/IDA) P15976 (/IDA) P17679 (/IDA) P23769 (/IDA) P23769 (/IDA) P23769 (/IDA) P23769 (/IDA)
(26 more)
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
11 D2HDE5 (/ISS) E2RPT1 (/ISS) P23825 (/ISS) P43693 (/ISS) P43694 (/ISS) P43694 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0Q0E4 (/ISS) Q0ZHH4 (/ISS)
(1 more)
Nucleoplasm GO:0005654
That part of the nuclear content other than the chromosomes or the nucleolus.
11 P15976 (/TAS) P23769 (/TAS) P23769 (/TAS) P23769 (/TAS) P23769 (/TAS) P23769 (/TAS) P23771 (/TAS) P43694 (/TAS) P43694 (/TAS) Q92908 (/TAS)
(1 more)
Nuclear chromatin GO:0000790
The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome in the nucleus.
8 D2HDE5 (/ISS) E2RPT1 (/ISS) P23825 (/ISS) Q08DV0 (/ISS) Q08DV0 (/ISS) Q0ZHH4 (/ISS) Q99NH5 (/ISS) Q9BWX5 (/ISS)
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
8 O09100 (/ISO) O09100 (/ISO) P17679 (/ISO) P23772 (/ISO) P23772 (/ISO) P97489 (/ISO) Q08369 (/ISO) Q61169 (/ISO)
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
6 P52168 (/IC) P52168 (/IC) P70005 (/IC) Q05AJ3 (/IC) Q90410 (/IC) Q99NH5 (/IC)
Nucleoplasm GO:0005654
That part of the nuclear content other than the chromosomes or the nucleolus.
6 P23769 (/IDA) P23769 (/IDA) P23769 (/IDA) P23769 (/IDA) P23769 (/IDA) P23771 (/IDA)
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
5 P23769 (/IDA) P23769 (/IDA) P23769 (/IDA) P23769 (/IDA) P23769 (/IDA)
Nucleoplasm GO:0005654
That part of the nuclear content other than the chromosomes or the nucleolus.
4 O09100 (/ISO) O09100 (/ISO) P23772 (/ISO) P23772 (/ISO)
Nuclear body GO:0016604
Extra-nucleolar nuclear domains usually visualized by confocal microscopy and fluorescent antibodies to specific proteins.
4 A0A087WZ09 (/IDA) A0A087WZ09 (/IDA) P43694 (/IDA) P43694 (/IDA)
Nuclear chromatin GO:0000790
The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome in the nucleus.
3 P23771 (/IDA) P97489 (/IDA) Q08369 (/IDA)
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
3 P43694 (/NAS) P43694 (/NAS) Q16365 (/NAS)
Nuclear chromatin GO:0000790
The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome in the nucleus.
2 P23772 (/ISO) P23772 (/ISO)
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
2 F1NZV5 (/IMP) P43692 (/IMP)
Transcription factor complex GO:0005667
A protein complex that is capable of associating with DNA by direct binding, or via other DNA-binding proteins or complexes, and regulating transcription.
2 P15976 (/IDA) Q61169 (/IDA)
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
2 O09100 (/ISO) O09100 (/ISO)
Protein-containing complex GO:0032991
A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which at least one component is a protein and the constituent parts function together.
2 O09100 (/IDA) O09100 (/IDA)
RNA polymerase II transcription factor complex GO:0090575
A transcription factor complex that acts at a regulatory region of a gene transcribed by RNA polymerase II.
2 P43694 (/IDA) P43694 (/IDA)
Transcription factor complex GO:0005667
A protein complex that is capable of associating with DNA by direct binding, or via other DNA-binding proteins or complexes, and regulating transcription.
1 P17679 (/ISO)
Nuclear body GO:0016604
Extra-nucleolar nuclear domains usually visualized by confocal microscopy and fluorescent antibodies to specific proteins.
1 Q08369 (/ISO)
Transcriptional repressor complex GO:0017053
A protein complex that possesses activity that prevents or downregulates transcription.
1 P15976 (/IDA)
Transcriptional repressor complex GO:0017053
A protein complex that possesses activity that prevents or downregulates transcription.
1 P17679 (/ISO)
Nuclear membrane GO:0031965
Either of the lipid bilayers that surround the nucleus and form the nuclear envelope; excludes the intermembrane space.
1 Q92908 (/IDA)
Nuclear membrane GO:0031965
Either of the lipid bilayers that surround the nucleus and form the nuclear envelope; excludes the intermembrane space.
1 Q61169 (/ISO)
Protein-DNA complex GO:0032993
A macromolecular complex containing both protein and DNA molecules.
1 P15976 (/IDA)
Protein-DNA complex GO:0032993
A macromolecular complex containing both protein and DNA molecules.
1 P17679 (/ISO)
RNA polymerase II transcription factor complex GO:0090575
A transcription factor complex that acts at a regulatory region of a gene transcribed by RNA polymerase II.
1 Q08369 (/ISO)